CZ303808B6 - Nové pyrazolové deriváty jako farmaceutická cinidla - Google Patents
Nové pyrazolové deriváty jako farmaceutická cinidla Download PDFInfo
- Publication number
- CZ303808B6 CZ303808B6 CZ20033128A CZ20033128A CZ303808B6 CZ 303808 B6 CZ303808 B6 CZ 303808B6 CZ 20033128 A CZ20033128 A CZ 20033128A CZ 20033128 A CZ20033128 A CZ 20033128A CZ 303808 B6 CZ303808 B6 CZ 303808B6
- Authority
- CZ
- Czechia
- Prior art keywords
- dihydro
- pyrrolo
- pyrazol
- pyridin
- quinoline
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title abstract description 3
- 150000003233 pyrroles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 219
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 20
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 17
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 14
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- -1 aminophenyl Chemical group 0.000 claims description 707
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 515
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 claims description 510
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 232
- 229910052739 hydrogen Inorganic materials 0.000 claims description 130
- 239000001257 hydrogen Substances 0.000 claims description 130
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 108
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 106
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 72
- 229910052757 nitrogen Inorganic materials 0.000 claims description 69
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 62
- WXXVQWSDMOAHHV-UHFFFAOYSA-N quinoline-7-carboxylic acid Chemical compound C1=CC=NC2=CC(C(=O)O)=CC=C21 WXXVQWSDMOAHHV-UHFFFAOYSA-N 0.000 claims description 62
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 59
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 48
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 45
- 229910052736 halogen Inorganic materials 0.000 claims description 44
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 42
- 125000000217 alkyl group Chemical group 0.000 claims description 42
- 125000003118 aryl group Chemical group 0.000 claims description 42
- HOGJMYWGRCJUQW-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxylic acid Chemical compound C=1C=NC2=CC(C(=O)O)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 HOGJMYWGRCJUQW-UHFFFAOYSA-N 0.000 claims description 41
- HNJBEVLQSNELDL-UHFFFAOYSA-N gamma-butyrolactam Natural products O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 40
- 150000002367 halogens Chemical class 0.000 claims description 37
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 33
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 33
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 31
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 28
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 28
- 150000001412 amines Chemical class 0.000 claims description 26
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 26
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 25
- 150000002431 hydrogen Chemical class 0.000 claims description 24
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- 150000001408 amides Chemical class 0.000 claims description 21
- 125000005843 halogen group Chemical group 0.000 claims description 21
- 238000006467 substitution reaction Methods 0.000 claims description 21
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 21
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 20
- 150000002148 esters Chemical class 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 19
- 125000004076 pyridyl group Chemical group 0.000 claims description 17
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 16
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 15
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 15
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 15
- 150000004702 methyl esters Chemical class 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 15
- MNLAVFKVRUQAKW-UHFFFAOYSA-N VR nerve agent Chemical compound CCN(CC)CCSP(C)(=O)OCC(C)C MNLAVFKVRUQAKW-UHFFFAOYSA-N 0.000 claims description 14
- 150000003857 carboxamides Chemical class 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 125000001544 thienyl group Chemical group 0.000 claims description 14
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 13
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 13
- 229940080818 propionamide Drugs 0.000 claims description 13
- 229910005965 SO 2 Inorganic materials 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 claims description 12
- RWRIWBAIICGTTQ-UHFFFAOYSA-N difluoromethane Chemical compound FCF RWRIWBAIICGTTQ-UHFFFAOYSA-N 0.000 claims description 12
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 11
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 11
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 11
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 11
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 11
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 11
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 11
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 11
- 150000003217 pyrazoles Chemical class 0.000 claims description 11
- FBNVOSBSLQPUBQ-UHFFFAOYSA-N quinolin-1-ium-7-sulfonate Chemical compound C1=CC=NC2=CC(S(=O)(=O)O)=CC=C21 FBNVOSBSLQPUBQ-UHFFFAOYSA-N 0.000 claims description 11
- XCRPPAPDRUBKRJ-UHFFFAOYSA-N quinolin-7-ol Chemical compound C1=CC=NC2=CC(O)=CC=C21 XCRPPAPDRUBKRJ-UHFFFAOYSA-N 0.000 claims description 11
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 10
- 125000006766 (C2-C6) alkynyloxy group Chemical group 0.000 claims description 10
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 10
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 10
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 10
- 125000001589 carboacyl group Chemical group 0.000 claims description 10
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 claims description 10
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 9
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 125000004423 acyloxy group Chemical group 0.000 claims description 9
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 9
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 9
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 9
- VXGYRCVTBHVXMZ-UHFFFAOYSA-N quinoline-6-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CC=C21 VXGYRCVTBHVXMZ-UHFFFAOYSA-N 0.000 claims description 9
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 8
- RHLRQCJZAXAGML-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-7-carboxylic acid Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(C=C3N=CC=2)C(O)=O)=N1 RHLRQCJZAXAGML-UHFFFAOYSA-N 0.000 claims description 8
- PIGFYZPCRLYGLF-UHFFFAOYSA-N Aluminum nitride Chemical compound [Al]#N PIGFYZPCRLYGLF-UHFFFAOYSA-N 0.000 claims description 8
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 8
- 150000003222 pyridines Chemical class 0.000 claims description 8
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 8
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 claims description 8
- 150000003248 quinolines Chemical class 0.000 claims description 8
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 7
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 7
- KJTRXVXWSSPHRV-UHFFFAOYSA-N 4-benzoyl-5-methyl-2-phenyl-1h-pyrazol-3-one Chemical compound O=C1C(C(=O)C=2C=CC=CC=2)=C(C)NN1C1=CC=CC=C1 KJTRXVXWSSPHRV-UHFFFAOYSA-N 0.000 claims description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 7
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 7
- 239000005977 Ethylene Substances 0.000 claims description 7
- GIIWGCBLYNDKBO-UHFFFAOYSA-N Quinoline 1-oxide Chemical compound C1=CC=C2[N+]([O-])=CC=CC2=C1 GIIWGCBLYNDKBO-UHFFFAOYSA-N 0.000 claims description 7
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 7
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 claims description 7
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 claims description 7
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 claims description 7
- QDVBKXJMLILLLB-UHFFFAOYSA-N 1,4'-bipiperidine Chemical compound C1CCCCN1C1CCNCC1 QDVBKXJMLILLLB-UHFFFAOYSA-N 0.000 claims description 6
- IRNAEDHJBNPCEZ-UHFFFAOYSA-N 1-n,1-n,2-trimethylpropane-1,2-diamine Chemical compound CN(C)CC(C)(C)N IRNAEDHJBNPCEZ-UHFFFAOYSA-N 0.000 claims description 6
- FHPLXZDRNSGYSK-UHFFFAOYSA-N 2-(1h-pyrazol-5-yl)quinoline Chemical compound N1N=CC=C1C1=CC=C(C=CC=C2)C2=N1 FHPLXZDRNSGYSK-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 6
- YOKUGHHDNXZKFC-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxylic acid Chemical compound C12=CC(C(=O)O)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 YOKUGHHDNXZKFC-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 6
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 6
- YDVJBLJCSLVMSY-UHFFFAOYSA-N carbamoyl cyanide Chemical compound NC(=O)C#N YDVJBLJCSLVMSY-UHFFFAOYSA-N 0.000 claims description 6
- 150000007942 carboxylates Chemical class 0.000 claims description 6
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims description 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims description 6
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims description 6
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 claims description 6
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 6
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims description 5
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 5
- ZTQKCBQVGOJTSS-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-sulfonic acid Chemical compound C=1C=NC2=CC(S(=O)(=O)O)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 ZTQKCBQVGOJTSS-UHFFFAOYSA-N 0.000 claims description 5
- MAQAGRJURDEYDQ-UHFFFAOYSA-N 6-methylpyridine Chemical compound CC1=C=CC=C[N]1 MAQAGRJURDEYDQ-UHFFFAOYSA-N 0.000 claims description 5
- PUCPFBRDUSBTHF-UHFFFAOYSA-N 7-(3-chloropropoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(OCCCCl)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 PUCPFBRDUSBTHF-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 5
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 4
- CJNRGSHEMCMUOE-UHFFFAOYSA-N 2-piperidin-1-ylethanamine Chemical compound NCCN1CCCCC1 CJNRGSHEMCMUOE-UHFFFAOYSA-N 0.000 claims description 4
- ZHNYCSVPOLBQEU-UHFFFAOYSA-N 2-pyridin-2-yl-3-quinolin-4-yl-6,7-dihydro-4h-pyrazolo[5,1-c][1,4]oxazine Chemical compound C=1C=NC2=CC=CC=C2C=1C1=C2COCCN2N=C1C1=CC=CC=N1 ZHNYCSVPOLBQEU-UHFFFAOYSA-N 0.000 claims description 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 4
- OXRWANGTCXYDBZ-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxylic acid Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(=CC=C3N=CC=2)C(O)=O)=N1 OXRWANGTCXYDBZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims description 4
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 4
- 125000005189 alkyl hydroxy group Chemical group 0.000 claims description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 4
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000002541 furyl group Chemical class 0.000 claims description 4
- PSXRWZBTVAZNSF-UHFFFAOYSA-N hydron;quinoline;chloride Chemical compound Cl.N1=CC=CC2=CC=CC=C21 PSXRWZBTVAZNSF-UHFFFAOYSA-N 0.000 claims description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 4
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims description 4
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 claims description 4
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 claims description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 4
- MMCIXNVRVDTQSG-UHFFFAOYSA-N quinoline-7-carboxamide Chemical compound C1=CC=NC2=CC(C(=O)N)=CC=C21 MMCIXNVRVDTQSG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- OPCJOXGBLDJWRM-UHFFFAOYSA-N 1,2-diamino-2-methylpropane Chemical compound CC(C)(N)CN OPCJOXGBLDJWRM-UHFFFAOYSA-N 0.000 claims description 3
- RRQHLOZQFPWDCA-UHFFFAOYSA-N 1-n,1-n-dimethylpropane-1,2-diamine Chemical compound CC(N)CN(C)C RRQHLOZQFPWDCA-UHFFFAOYSA-N 0.000 claims description 3
- KAUABWYBFARJAF-UHFFFAOYSA-N 1h-pyrazol-4-ol Chemical compound OC=1C=NNC=1 KAUABWYBFARJAF-UHFFFAOYSA-N 0.000 claims description 3
- BTDQXGUEVVTAMD-UHFFFAOYSA-N 2-hydroxyethyl carbamate Chemical compound NC(=O)OCCO BTDQXGUEVVTAMD-UHFFFAOYSA-N 0.000 claims description 3
- VJROPLWGFCORRM-UHFFFAOYSA-N 2-methylbutan-1-amine Chemical compound CCC(C)CN VJROPLWGFCORRM-UHFFFAOYSA-N 0.000 claims description 3
- JFQHZKYTJUOQDK-UHFFFAOYSA-N 3-(4-fluorophenyl)-2-[6-(trifluoromethyl)pyridin-2-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound C1=CC(F)=CC=C1C(C(=N1)C=2N=C(C=CC=2)C(F)(F)F)=C2N1CCC2 JFQHZKYTJUOQDK-UHFFFAOYSA-N 0.000 claims description 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 3
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 3
- VPBWZBGZWHDNKL-UHFFFAOYSA-N 3-pyrrolidin-1-ylpropan-1-amine Chemical compound NCCCN1CCCC1 VPBWZBGZWHDNKL-UHFFFAOYSA-N 0.000 claims description 3
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims description 3
- XQSJEJADIIGXBO-UHFFFAOYSA-N 7-(2-propoxyethoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(OCCOCCC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 XQSJEJADIIGXBO-UHFFFAOYSA-N 0.000 claims description 3
- SGBDJDBCJFNUJF-UHFFFAOYSA-N 7-methoxy-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C=1C=NC2=CC(OC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 SGBDJDBCJFNUJF-UHFFFAOYSA-N 0.000 claims description 3
- QIOZLISABUUKJY-UHFFFAOYSA-N Thiobenzamide Chemical compound NC(=S)C1=CC=CC=C1 QIOZLISABUUKJY-UHFFFAOYSA-N 0.000 claims description 3
- 150000001350 alkyl halides Chemical class 0.000 claims description 3
- HWDVTQAXQJQROO-UHFFFAOYSA-N cyclopropylazanide Chemical compound [NH-]C1CC1 HWDVTQAXQJQROO-UHFFFAOYSA-N 0.000 claims description 3
- UZBQIPPOMKBLAS-UHFFFAOYSA-N diethylazanide Chemical compound CC[N-]CC UZBQIPPOMKBLAS-UHFFFAOYSA-N 0.000 claims description 3
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 3
- SORARJZLMNRBAQ-UHFFFAOYSA-N n,n',n'-trimethylpropane-1,3-diamine Chemical compound CNCCCN(C)C SORARJZLMNRBAQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 3
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 claims description 3
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 claims description 3
- HFAFXVOPGDBAOK-UHFFFAOYSA-N pyridine-2-carbonyloxidanium;chloride Chemical compound Cl.OC(=O)C1=CC=CC=N1 HFAFXVOPGDBAOK-UHFFFAOYSA-N 0.000 claims description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 3
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 claims description 3
- UWDJTGUBOOQHLM-JOCHJYFZSA-N (6r)-3-(4-fluorophenyl)-2-(6-methylpyridin-2-yl)-6-(phenylmethoxymethyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CC[C@H](COCC=4C=CC=CC=4)N3N=2)C=2C=CC(F)=CC=2)=N1 UWDJTGUBOOQHLM-JOCHJYFZSA-N 0.000 claims description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 2
- GTBXZWADMKOZQJ-UHFFFAOYSA-N 1-phenanthrol Chemical group C1=CC2=CC=CC=C2C2=C1C(O)=CC=C2 GTBXZWADMKOZQJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 2
- SRKYLKIHKAYHJA-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-naphthalen-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=C3C=CC=CC3=CC=2)=N1 SRKYLKIHKAYHJA-UHFFFAOYSA-N 0.000 claims description 2
- QXQQGSLVFLDSRK-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-pyridin-3-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=NC=CC=2)=N1 QXQQGSLVFLDSRK-UHFFFAOYSA-N 0.000 claims description 2
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 claims description 2
- LAVVISXEUOZAMM-UHFFFAOYSA-N 2-chloro-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=12C=CC=CC2=NC(Cl)=CC=1C1=C2CCCN2N=C1C1=CC=CC=N1 LAVVISXEUOZAMM-UHFFFAOYSA-N 0.000 claims description 2
- QAQJKDRAJZWQCM-UHFFFAOYSA-N 2-methoxyethyl carbamate Chemical compound COCCOC(N)=O QAQJKDRAJZWQCM-UHFFFAOYSA-N 0.000 claims description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 2
- ZEDSQFCGFUHLRN-UHFFFAOYSA-N 2-pyridin-2-yl-3-pyridin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound N=1N2CCCC2=C(C=2C=CN=CC=2)C=1C1=CC=CC=N1 ZEDSQFCGFUHLRN-UHFFFAOYSA-N 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- LSAAJWRJWSODCN-UHFFFAOYSA-N 3-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1C1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 LSAAJWRJWSODCN-UHFFFAOYSA-N 0.000 claims description 2
- UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 claims description 2
- UWICNGHOBHTGAK-UHFFFAOYSA-N 3-naphthalen-2-yl-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound N=1N2CCCC2=C(C=2C=C3C=CC=CC3=CC=2)C=1C1=CC=CC=N1 UWICNGHOBHTGAK-UHFFFAOYSA-N 0.000 claims description 2
- MYIPOPKHTPBLMM-UHFFFAOYSA-N 4-(2-pyrazin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CN=CC=N1 MYIPOPKHTPBLMM-UHFFFAOYSA-N 0.000 claims description 2
- HATIKTCJTMHFQL-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-7-(2-pyrrolidin-1-ylethoxy)quinoline Chemical compound C=1C=C2C(C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)=CC=NC2=CC=1OCCN1CCCC1 HATIKTCJTMHFQL-UHFFFAOYSA-N 0.000 claims description 2
- VTZXENNHZAMOHE-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-7-[3-(pyridin-2-ylmethylsulfonyl)propoxy]quinoline Chemical compound C=1C=CC=NC=1CS(=O)(=O)CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 VTZXENNHZAMOHE-UHFFFAOYSA-N 0.000 claims description 2
- IBIAUAYUNZFZJA-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-amine Chemical compound C=1C=NC2=CC(N)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 IBIAUAYUNZFZJA-UHFFFAOYSA-N 0.000 claims description 2
- ATMZZCMTDCRJJX-UHFFFAOYSA-N 4-(3-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)quinoline Chemical compound C=1C=NC2=CC=CC=C2C=1C1=NN2CCCC2=C1C1=CC=CC=N1 ATMZZCMTDCRJJX-UHFFFAOYSA-N 0.000 claims description 2
- VPECVOLJZWWFCZ-UHFFFAOYSA-N 4-[2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound C1=CC(F)=CC=C1C1=NN(CCCC2)C2=C1C1=CC=NC2=CC=CC=C12 VPECVOLJZWWFCZ-UHFFFAOYSA-N 0.000 claims description 2
- CLOYZHLLEAYAGZ-UHFFFAOYSA-N 4-[2-(6-chloropyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound ClC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 CLOYZHLLEAYAGZ-UHFFFAOYSA-N 0.000 claims description 2
- KLRSNFDKGMZTNZ-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-7-propan-2-yloxyquinoline Chemical compound C=1C=NC2=CC(OC(C)C)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 KLRSNFDKGMZTNZ-UHFFFAOYSA-N 0.000 claims description 2
- CQFMEEGANZACLR-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 CQFMEEGANZACLR-UHFFFAOYSA-N 0.000 claims description 2
- FXINJBRWUHKTTG-UHFFFAOYSA-N 4-[2-(6-phenylsulfanylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C(N=1)=CC=CC=1SC1=CC=CC=C1 FXINJBRWUHKTTG-UHFFFAOYSA-N 0.000 claims description 2
- KPRZDYKKLXFIFH-UHFFFAOYSA-N 4-[2-[3-(trifluoromethoxy)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound FC(F)(F)OC1=CC=CC(C=2C(=C3CCCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 KPRZDYKKLXFIFH-UHFFFAOYSA-N 0.000 claims description 2
- FJELBUOWEFSMQU-UHFFFAOYSA-N 4-[2-[3-fluoro-5-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound FC(F)(F)C1=CC(F)=CC(C=2C(=C3CCCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 FJELBUOWEFSMQU-UHFFFAOYSA-N 0.000 claims description 2
- UQHBONBKLBBULF-UHFFFAOYSA-N 4-[2-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NN(CCCC2)C2=C1C1=CC=NC2=CC=CC=C12 UQHBONBKLBBULF-UHFFFAOYSA-N 0.000 claims description 2
- LBNOXWPVZFDPPK-UHFFFAOYSA-N 4-[2-[4-fluoro-3-(trifluoromethyl)phenyl]-5-(3-methoxyphenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound COC1=CC=CC(C2CN3N=C(C(=C3C2)C=2C3=CC=CC=C3N=CC=2)C=2C=C(C(F)=CC=2)C(F)(F)F)=C1 LBNOXWPVZFDPPK-UHFFFAOYSA-N 0.000 claims description 2
- SFHOJUNHMNZMEP-UHFFFAOYSA-N 4-[3-(5-fluoropyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-4-yl]quinoline Chemical compound N1=CC(F)=CC=C1C1=C2C(C=3C4=CC=CC=C4N=CC=3)CCN2N=C1 SFHOJUNHMNZMEP-UHFFFAOYSA-N 0.000 claims description 2
- JVQUPGSXRKSUPU-UHFFFAOYSA-N 4-[3-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=NN3CCCC3=2)C=2C3=CC=CC=C3N=CC=2)=N1 JVQUPGSXRKSUPU-UHFFFAOYSA-N 0.000 claims description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims description 2
- WYXGEPINSYNEEY-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-yl)-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(=CC=C3N=CC=2)C=2C=C3OCOC3=CC=2)=N1 WYXGEPINSYNEEY-UHFFFAOYSA-N 0.000 claims description 2
- BJBCSMYAHPXGJA-UHFFFAOYSA-N 6-bromo-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(Br)=CC=C3N=CC=2)=N1 BJBCSMYAHPXGJA-UHFFFAOYSA-N 0.000 claims description 2
- NMCMJCPBGFTKLK-UHFFFAOYSA-N 6-methoxy-7-phenylmethoxy-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound COC1=CC2=C(C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C=CN=C2C=C1OCC1=CC=CC=C1 NMCMJCPBGFTKLK-UHFFFAOYSA-N 0.000 claims description 2
- AEYKDMKKMQFCOC-UHFFFAOYSA-N 6-methylsulfanyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C12=CC(SC)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 AEYKDMKKMQFCOC-UHFFFAOYSA-N 0.000 claims description 2
- WHPDEQWYLOZNRB-UHFFFAOYSA-N 7-(3-chloropropylsulfanyl)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(SCCCCl)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 WHPDEQWYLOZNRB-UHFFFAOYSA-N 0.000 claims description 2
- BADBQBGYQFPQKB-UHFFFAOYSA-N 7-(3-fluoropropoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(OCCCF)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 BADBQBGYQFPQKB-UHFFFAOYSA-N 0.000 claims description 2
- KXNLBPWSAUOGQQ-UHFFFAOYSA-N 7-[2-(1-methylpyrrolidin-2-yl)ethoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline;hydrochloride Chemical compound Cl.CN1CCCC1CCOC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 KXNLBPWSAUOGQQ-UHFFFAOYSA-N 0.000 claims description 2
- LMOKFGDYXXIENY-UHFFFAOYSA-N 7-[3-(4-chlorophenyl)sulfonylpropoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)CCCOC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 LMOKFGDYXXIENY-UHFFFAOYSA-N 0.000 claims description 2
- XUNIUWPTUZPEDT-UHFFFAOYSA-N 7-[3-(4-methylpiperazin-1-yl)propoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 XUNIUWPTUZPEDT-UHFFFAOYSA-N 0.000 claims description 2
- HARDZWAIHQFCPS-UHFFFAOYSA-N 7-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound COC1=CC=CC=C1N1CCN(CCCOC=2C=C3N=CC=C(C3=CC=2)C=2C(=NN3CCCC3=2)C=2N=CC=CC=2)CC1 HARDZWAIHQFCPS-UHFFFAOYSA-N 0.000 claims description 2
- DHPHPFQVYRNHRD-UHFFFAOYSA-N 7-bromo-2-propan-2-yl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=12C=CC(Br)=CC2=NC(C(C)C)=CC=1C1=C2CCCN2N=C1C1=CC=CC=N1 DHPHPFQVYRNHRD-UHFFFAOYSA-N 0.000 claims description 2
- PCKFABJLKSXQEV-UHFFFAOYSA-N 7-bromo-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(Br)C=C3N=CC=2)=N1 PCKFABJLKSXQEV-UHFFFAOYSA-N 0.000 claims description 2
- KJIVUWQLUOPVDT-UHFFFAOYSA-N 7-chloro-4-(3-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-4-yl)quinoline Chemical compound C=1C=NC2=CC(Cl)=CC=C2C=1C(C=12)CCN2N=CC=1C1=CC=CC=N1 KJIVUWQLUOPVDT-UHFFFAOYSA-N 0.000 claims description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 2
- HGQPVXDOFCEDIZ-UHFFFAOYSA-N N-tert-butylquinoline-7-carboxamide Chemical compound CC(C)(C)NC(=O)c1ccc2cccnc2c1 HGQPVXDOFCEDIZ-UHFFFAOYSA-N 0.000 claims description 2
- HFEFMUSTGZNOPY-UHFFFAOYSA-N OOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOO HFEFMUSTGZNOPY-UHFFFAOYSA-N 0.000 claims description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Natural products C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 2
- ZXKINMCYCKHYFR-UHFFFAOYSA-N aminooxidanide Chemical compound [O-]N ZXKINMCYCKHYFR-UHFFFAOYSA-N 0.000 claims description 2
- 150000005528 benzodioxoles Chemical class 0.000 claims description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- XRLDSWLMHUQECH-UHFFFAOYSA-N cyclopentanecarboxamide Chemical compound NC(=O)C1CCCC1 XRLDSWLMHUQECH-UHFFFAOYSA-N 0.000 claims description 2
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 claims description 2
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims description 2
- GDFHWCUOOVLQIC-UHFFFAOYSA-N methyl 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxylate Chemical compound C=1C=NC2=CC(C(=O)OC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 GDFHWCUOOVLQIC-UHFFFAOYSA-N 0.000 claims description 2
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 claims description 2
- DAKZISABEDGGSV-UHFFFAOYSA-N n-(2-aminoethyl)acetamide Chemical compound CC(=O)NCCN DAKZISABEDGGSV-UHFFFAOYSA-N 0.000 claims description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 2
- 150000002790 naphthalenes Chemical class 0.000 claims description 2
- 150000005054 naphthyridines Chemical class 0.000 claims description 2
- 125000004043 oxo group Chemical group O=* 0.000 claims description 2
- LYKMMUBOEFYJQG-UHFFFAOYSA-N piperoxan Chemical class C1OC2=CC=CC=C2OC1CN1CCCCC1 LYKMMUBOEFYJQG-UHFFFAOYSA-N 0.000 claims description 2
- 150000003216 pyrazines Chemical class 0.000 claims description 2
- 150000003230 pyrimidines Chemical class 0.000 claims description 2
- 150000003246 quinazolines Chemical class 0.000 claims description 2
- YMNAJWHTELQUJU-UHFFFAOYSA-N quinoline-6-carboxamide Chemical compound N1=CC=CC2=CC(C(=O)N)=CC=C21 YMNAJWHTELQUJU-UHFFFAOYSA-N 0.000 claims description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 2
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- ZGQYKHCUXXQSFO-UHFFFAOYSA-N 6,7-difluoro-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(F)=C(F)C=C3N=CC=2)=N1 ZGQYKHCUXXQSFO-UHFFFAOYSA-N 0.000 claims 4
- CPZFJIXACLCVLI-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C2=NN3CCCC3=C2)=N1 CPZFJIXACLCVLI-UHFFFAOYSA-N 0.000 claims 3
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 2
- UPYNRPVSMJWGRD-UHFFFAOYSA-N 2-(3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)quinoline Chemical compound C1=CC=C2C(C3=C4CCCN4N=C3C=3N=C4C=CC=CC4=CC=3)=CC=NC2=C1 UPYNRPVSMJWGRD-UHFFFAOYSA-N 0.000 claims 2
- XWBIPCWLLDJDJX-UHFFFAOYSA-N 3-(7-bromoquinolin-4-yl)-2-pyridin-2-yl-5,6-dihydropyrrolo[1,2-b]pyrazol-4-one Chemical compound C=1C=NC2=CC(Br)=CC=C2C=1C(=C1C(=O)CCN1N=1)C=1C1=CC=CC=N1 XWBIPCWLLDJDJX-UHFFFAOYSA-N 0.000 claims 2
- PYKNNLBCEGPGQU-UHFFFAOYSA-N 3-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxypropan-1-amine Chemical compound C=1C=NC2=CC(OCCCN)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 PYKNNLBCEGPGQU-UHFFFAOYSA-N 0.000 claims 2
- KDFYOXRREXHZSV-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-sulfonamide Chemical compound C=1C=NC2=CC(S(=O)(=O)N)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 KDFYOXRREXHZSV-UHFFFAOYSA-N 0.000 claims 2
- XMOADRUOAGNEDB-UHFFFAOYSA-N 7-(3-pyrazol-1-ylpropoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1=CC=NN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 XMOADRUOAGNEDB-UHFFFAOYSA-N 0.000 claims 2
- YOXUJEKTIANZNU-UHFFFAOYSA-N 7-methoxy-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(OC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 YOXUJEKTIANZNU-UHFFFAOYSA-N 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- ZIQIQOUPRHPOIT-UHFFFAOYSA-N cyclobutylazanide Chemical compound [NH-]C1CCC1 ZIQIQOUPRHPOIT-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- OYIKUZXYMXOTEP-UHFFFAOYSA-N n,n-dimethylquinoline-7-carboxamide Chemical compound C1=CC=NC2=CC(C(=O)N(C)C)=CC=C21 OYIKUZXYMXOTEP-UHFFFAOYSA-N 0.000 claims 2
- RCDSYZGPGNWOES-UHFFFAOYSA-N quinoline-7-carbohydrazide Chemical compound C1=CC=NC2=CC(C(=O)NN)=CC=C21 RCDSYZGPGNWOES-UHFFFAOYSA-N 0.000 claims 2
- SCUVRWANFFLUOS-UHFFFAOYSA-N (2-pyridin-2-yl-3-quinolin-4-yl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-7-yl) acetate Chemical compound N=1N2C(OC(=O)C)CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 SCUVRWANFFLUOS-UHFFFAOYSA-N 0.000 claims 1
- XUNKPNYCNUKOAU-VXJRNSOOSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]a Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XUNKPNYCNUKOAU-VXJRNSOOSA-N 0.000 claims 1
- NYYWVAFTGOFKGQ-UHFFFAOYSA-N (4-methylpiperazin-1-yl)-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 NYYWVAFTGOFKGQ-UHFFFAOYSA-N 0.000 claims 1
- VJCZDLCETZMJBK-UHFFFAOYSA-N 1,3-bis[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]urea Chemical compound C=1C=C2C(C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)=CC=NC2=CC=1NC(=O)NC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 VJCZDLCETZMJBK-UHFFFAOYSA-N 0.000 claims 1
- RSIFDNXAMFGKJB-UHFFFAOYSA-N 1-(2-hydroxyethyl)-3-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]urea Chemical compound C=1C=NC2=CC(NC(=O)NCCO)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 RSIFDNXAMFGKJB-UHFFFAOYSA-N 0.000 claims 1
- NKSCBIJGDJZCPJ-UHFFFAOYSA-N 1-[1-(6-methylpyridin-2-yl)-2-quinolin-4-yl-2,4,5,6-tetrahydropyrrolo[1,2-b]pyrazol-3-yl]-2h-quinoline-7-carboxylic acid Chemical compound CC1=CC=CC(N2N3CCCC3=C(N3C4=CC(=CC=C4C=CC3)C(O)=O)C2C=2C3=CC=CC=C3N=CC=2)=N1 NKSCBIJGDJZCPJ-UHFFFAOYSA-N 0.000 claims 1
- YJVXJFPEEUCNIA-UHFFFAOYSA-N 1-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]imidazolidin-2-one Chemical compound O=C1NCCN1C1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 YJVXJFPEEUCNIA-UHFFFAOYSA-N 0.000 claims 1
- QMZFSGIRWKYROC-UHFFFAOYSA-N 1-[[1-(6-methylpyridin-2-yl)-2-(4-methylsulfonylphenyl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=CC(=CC=2)S(C)(=O)=O)=NN2C(CCC2)=O)=N1 QMZFSGIRWKYROC-UHFFFAOYSA-N 0.000 claims 1
- KSZCAGWHZCZJLZ-UHFFFAOYSA-N 1-methylimidazole-4-sulfonic acid Chemical compound CN1C=NC(S(O)(=O)=O)=C1 KSZCAGWHZCZJLZ-UHFFFAOYSA-N 0.000 claims 1
- GPCQNIQJHLQPLC-UHFFFAOYSA-N 2-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxylic acid Chemical compound N=1C2=CC(C(=O)O)=CC=C2C=CC=1C1=C2CCCN2N=C1C1=CC=CC=N1 GPCQNIQJHLQPLC-UHFFFAOYSA-N 0.000 claims 1
- QZYNOXKZNJMPAK-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-naphthalen-1-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3C=CC=2)=N1 QZYNOXKZNJMPAK-UHFFFAOYSA-N 0.000 claims 1
- PYWGEAAAFXYTJF-UHFFFAOYSA-N 2-(pyridin-4-ylmethoxy)quinoline Chemical compound C=1C=C2C=CC=CC2=NC=1OCC1=CC=NC=C1 PYWGEAAAFXYTJF-UHFFFAOYSA-N 0.000 claims 1
- AKEQYYGHELROLY-MRXNPFEDSA-N 2-[(6r)-3-(4-fluorophenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-6-yl]acetonitrile Chemical compound CC1=CC=CC(C=2C(=C3CC[C@H](CC#N)N3N=2)C=2C=CC(F)=CC=2)=N1 AKEQYYGHELROLY-MRXNPFEDSA-N 0.000 claims 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims 1
- MPJSNWLTOASGCO-UHFFFAOYSA-N 2-pyridin-2-yl-3-quinolin-4-yl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-7-ol Chemical compound N=1N2C(O)CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 MPJSNWLTOASGCO-UHFFFAOYSA-N 0.000 claims 1
- JUTSNOFITSKDFP-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=C3OCOC3=CC=2)=N1 JUTSNOFITSKDFP-UHFFFAOYSA-N 0.000 claims 1
- LFDMOHFJOFXXIA-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C(=CC(F)=CC=2)Cl)=N1 LFDMOHFJOFXXIA-UHFFFAOYSA-N 0.000 claims 1
- OUXOROCQTQKSMG-UHFFFAOYSA-N 3-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]sulfanylpropan-1-ol Chemical compound C=1C=NC2=CC(SCCCO)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 OUXOROCQTQKSMG-UHFFFAOYSA-N 0.000 claims 1
- AKKGSZWSGFUTSR-UHFFFAOYSA-N 3-[4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinolin-6-yl]prop-2-enoic acid Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(C=CC(O)=O)=CC=C3N=CC=2)=N1 AKKGSZWSGFUTSR-UHFFFAOYSA-N 0.000 claims 1
- JDFYGBYGPFGTIN-UHFFFAOYSA-N 3-[6-methoxy-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxy-n,n-dimethylpropan-1-amine Chemical compound C1=CN=C2C=C(OCCCN(C)C)C(OC)=CC2=C1C1=C2CCCN2N=C1C1=CC=CC=N1 JDFYGBYGPFGTIN-UHFFFAOYSA-N 0.000 claims 1
- TXDXMOSVZSMQRA-UHFFFAOYSA-N 3-bromo-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical group CC1=CC=CC(C=2C(=C3CCCN3N=2)Br)=N1 TXDXMOSVZSMQRA-UHFFFAOYSA-N 0.000 claims 1
- CRLACYJTDCLJEF-UHFFFAOYSA-N 4-(2-phenyl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=C1 CRLACYJTDCLJEF-UHFFFAOYSA-N 0.000 claims 1
- WYCHTDNIDFWLQN-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinoline Chemical compound C1CCCN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 WYCHTDNIDFWLQN-UHFFFAOYSA-N 0.000 claims 1
- CEEIVMLJLRXSOA-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxamide Chemical compound C=1C=NC2=CC(C(=O)N)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 CEEIVMLJLRXSOA-UHFFFAOYSA-N 0.000 claims 1
- CWPKKMKVGXGFCY-UHFFFAOYSA-N 4-(2-thiophen-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CS1 CWPKKMKVGXGFCY-UHFFFAOYSA-N 0.000 claims 1
- UQAACURFOMAWGN-UHFFFAOYSA-N 4-(3-quinolin-2-yloxypropyl)morpholine Chemical compound C=1C=C2C=CC=CC2=NC=1OCCCN1CCOCC1 UQAACURFOMAWGN-UHFFFAOYSA-N 0.000 claims 1
- WMMSFXCNQQVVFE-UHFFFAOYSA-N 4-(7-phenylmethoxy-2-pyridin-2-yl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)quinoline Chemical compound C=1C=CC=CC=1COC(N1N=2)CCCC1=C(C=1C3=CC=CC=C3N=CC=1)C=2C1=CC=CC=N1 WMMSFXCNQQVVFE-UHFFFAOYSA-N 0.000 claims 1
- MWPWTAHAQDSKSE-UHFFFAOYSA-N 4-[2-(4-fluorophenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1=CC(F)=CC=C1C1=NN(CCC2)C2=C1C1=CC=NC2=CC=CC=C12 MWPWTAHAQDSKSE-UHFFFAOYSA-N 0.000 claims 1
- KZMBKCUGOJXAGQ-UHFFFAOYSA-N 4-[2-(6-bromopyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound BrC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 KZMBKCUGOJXAGQ-UHFFFAOYSA-N 0.000 claims 1
- JRVQJDMLNOTTME-UHFFFAOYSA-N 4-[2-(6-ethoxypyridin-2-yl)-5-(4-fluorophenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CCOC1=CC=CC(C=2C(=C3CC(CN3N=2)C=2C=CC(F)=CC=2)C=2C3=CC=CC=C3N=CC=2)=N1 JRVQJDMLNOTTME-UHFFFAOYSA-N 0.000 claims 1
- GWAQROYAJBJLDD-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-7-propoxyquinoline Chemical compound C=1C=NC2=CC(OCCC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 GWAQROYAJBJLDD-UHFFFAOYSA-N 0.000 claims 1
- PBLNPFVCOVYAKI-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-7-carboxamide Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(C=C3N=CC=2)C(N)=O)=N1 PBLNPFVCOVYAKI-UHFFFAOYSA-N 0.000 claims 1
- LKAFYHZXFLKTMU-UHFFFAOYSA-N 4-[2-(6-phenylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C(N=1)=CC=CC=1C1=CC=CC=C1 LKAFYHZXFLKTMU-UHFFFAOYSA-N 0.000 claims 1
- MYNYRQXACWERLQ-UHFFFAOYSA-N 4-[2-(6-propan-2-ylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC(C)C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 MYNYRQXACWERLQ-UHFFFAOYSA-N 0.000 claims 1
- NLLDXCHGAPIYIZ-UHFFFAOYSA-N 4-[2-(6-propylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CCCC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 NLLDXCHGAPIYIZ-UHFFFAOYSA-N 0.000 claims 1
- MXJDWTSVBHPQOI-UHFFFAOYSA-N 4-[2-[2-fluoro-3-(trifluoromethyl)phenyl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1=CC=C(C(F)(F)F)C(F)=C1C1=NN(CCC2)C2=C1C1=CC=NC2=CC=CC=C12 MXJDWTSVBHPQOI-UHFFFAOYSA-N 0.000 claims 1
- RGZMRFKZXQNTBL-UHFFFAOYSA-N 4-[5-(2-phenylethyl)-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1C2=C(C=3C4=CC=CC=C4N=CC=3)C(C=3N=CC=CC=3)=NN2CC1CCC1=CC=CC=C1 RGZMRFKZXQNTBL-UHFFFAOYSA-N 0.000 claims 1
- LMSZHOJBUVZTHH-UHFFFAOYSA-N 6,7-dichloro-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(Cl)=C(Cl)C=C3N=CC=2)=N1 LMSZHOJBUVZTHH-UHFFFAOYSA-N 0.000 claims 1
- NKYSUJOKNIVAEF-UHFFFAOYSA-N 6,7-dimethoxy-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 NKYSUJOKNIVAEF-UHFFFAOYSA-N 0.000 claims 1
- MYJDIHLJGSWDAL-UHFFFAOYSA-N 6-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C=C3C=CC=NC3=CC=2)C=1C1=CC=CC=N1 MYJDIHLJGSWDAL-UHFFFAOYSA-N 0.000 claims 1
- YBXYYSXBUBLDJT-UHFFFAOYSA-N 6-(4-fluorophenyl)-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(=CC=C3N=CC=2)C=2C=CC(F)=CC=2)=N1 YBXYYSXBUBLDJT-UHFFFAOYSA-N 0.000 claims 1
- FWNLISFGKWNPNX-UHFFFAOYSA-N 6-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=C3C=CC=NC3=CC=2)=N1 FWNLISFGKWNPNX-UHFFFAOYSA-N 0.000 claims 1
- VYXKTNXWRUPDGG-UHFFFAOYSA-N 6-ethylpyridine Chemical compound CCC1=C=CC=C[N]1 VYXKTNXWRUPDGG-UHFFFAOYSA-N 0.000 claims 1
- IMHSJNYKMJCABK-UHFFFAOYSA-N 6-methoxy-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol Chemical compound C1=CN=C2C=C(O)C(OC)=CC2=C1C1=C2CCCN2N=C1C1=CC=CC=N1 IMHSJNYKMJCABK-UHFFFAOYSA-N 0.000 claims 1
- CXQABHUJQZTBBL-UHFFFAOYSA-N 6-methylsulfonyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C12=CC(S(=O)(=O)C)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 CXQABHUJQZTBBL-UHFFFAOYSA-N 0.000 claims 1
- LSLFAANQEYOVFU-UHFFFAOYSA-N 7-(3-piperidin-1-ylpropoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1CCCCN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 LSLFAANQEYOVFU-UHFFFAOYSA-N 0.000 claims 1
- XANWPXWHHGSPEP-UHFFFAOYSA-N 7-(4,5-dihydro-1h-imidazol-2-yl)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=C(C=C3N=CC=2)C=2NCCN=2)C=1C1=CC=CC=N1 XANWPXWHHGSPEP-UHFFFAOYSA-N 0.000 claims 1
- UGILNCNJARFIDN-UHFFFAOYSA-N 7-[(1-methylpiperidin-3-yl)methoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1N(C)CCCC1COC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 UGILNCNJARFIDN-UHFFFAOYSA-N 0.000 claims 1
- CZJYSTBYBBEADR-UHFFFAOYSA-N 7-[3-(azepan-1-yl)propoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1CCCCCN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 CZJYSTBYBBEADR-UHFFFAOYSA-N 0.000 claims 1
- FNFTYYKPWLFASR-UHFFFAOYSA-N 7-bromo-4-(3-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-4-yl)quinoline Chemical compound C=1C=NC2=CC(Br)=CC=C2C=1C(C=12)CCN2N=CC=1C1=CC=CC=N1 FNFTYYKPWLFASR-UHFFFAOYSA-N 0.000 claims 1
- HMBSLOMTNYRXPE-UHFFFAOYSA-N 7-bromo-4-(4-methoxy-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(Br)=CC=C2C=1C1=C2C(OC)CCN2N=C1C1=CC=CC=N1 HMBSLOMTNYRXPE-UHFFFAOYSA-N 0.000 claims 1
- XYBSZCUHOLWQQU-UHFFFAOYSA-N 7-bromoquinoline Chemical compound C1=CC=NC2=CC(Br)=CC=C21 XYBSZCUHOLWQQU-UHFFFAOYSA-N 0.000 claims 1
- MUSZWUQYXOWRMX-UHFFFAOYSA-N 7-chloro-4-[3-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-4-yl]quinoline Chemical compound CC1=CC=CC(C2=C3C(CCN3N=C2)C=2C3=CC=C(Cl)C=C3N=CC=2)=N1 MUSZWUQYXOWRMX-UHFFFAOYSA-N 0.000 claims 1
- CXFUMQXKEITWKR-UHFFFAOYSA-N 7-ethylsulfanyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(SCC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 CXFUMQXKEITWKR-UHFFFAOYSA-N 0.000 claims 1
- HCQZLDOVFMMADK-UHFFFAOYSA-N 7-methylsulfanyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(SC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 HCQZLDOVFMMADK-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 claims 1
- BLNXICBKZVWPHJ-UHFFFAOYSA-N N-[2-(dimethylamino)ethyl]quinoline-7-carboxamide Chemical compound CN(CCNC(=O)C1=CC=C2C=CC=NC2=C1)C BLNXICBKZVWPHJ-UHFFFAOYSA-N 0.000 claims 1
- GUTJOUHYHYHOLP-UHFFFAOYSA-N N-[3-(dimethylamino)propyl]quinoline-7-carboxamide Chemical compound CN(CCCNC(=O)C1=CC=C2C=CC=NC2=C1)C GUTJOUHYHYHOLP-UHFFFAOYSA-N 0.000 claims 1
- QTMQNUHRVZOGFO-UHFFFAOYSA-N N-methylquinoline-7-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C2C=CC=NC2=C1 QTMQNUHRVZOGFO-UHFFFAOYSA-N 0.000 claims 1
- IWSXTDZQPVLAFO-UHFFFAOYSA-N N1(CCOCC1)CCCNC(=O)C1=CC=C2C=CC=NC2=C1 Chemical compound N1(CCOCC1)CCCNC(=O)C1=CC=C2C=CC=NC2=C1 IWSXTDZQPVLAFO-UHFFFAOYSA-N 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- MSZJEPVVQWJCIF-UHFFFAOYSA-N butylazanide Chemical compound CCCC[NH-] MSZJEPVVQWJCIF-UHFFFAOYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 1
- 150000001854 cinnolines Chemical class 0.000 claims 1
- GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical compound C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims 1
- WUSBWWWXKVBGOW-UHFFFAOYSA-N methyl 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-7-carboxylate Chemical compound C=1C=NC2=CC(C(=O)OC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 WUSBWWWXKVBGOW-UHFFFAOYSA-N 0.000 claims 1
- RQMSVRBTBHONAQ-UHFFFAOYSA-N methyl 6-(3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)pyridine-2-carboxylate Chemical compound COC(=O)C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 RQMSVRBTBHONAQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- SKECXRFZFFAANN-UHFFFAOYSA-N n,n-dimethylmethanethioamide Chemical compound CN(C)C=S SKECXRFZFFAANN-UHFFFAOYSA-N 0.000 claims 1
- RDYVQMITLISYRF-UHFFFAOYSA-N n-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]methanesulfonamide Chemical compound C=1C=NC2=CC(NS(=O)(=O)C)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 RDYVQMITLISYRF-UHFFFAOYSA-N 0.000 claims 1
- SDSWYVKQOCTLKH-UHFFFAOYSA-N n-hydroxyquinoline-7-carboxamide Chemical compound C1=CC=NC2=CC(C(=O)NO)=CC=C21 SDSWYVKQOCTLKH-UHFFFAOYSA-N 0.000 claims 1
- RMWOOXGUUFOFFN-UHFFFAOYSA-N n-methyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-sulfonamide Chemical compound C=1C=NC2=CC(S(=O)(=O)NC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 RMWOOXGUUFOFFN-UHFFFAOYSA-N 0.000 claims 1
- GCJYRIRCTQDLJX-UHFFFAOYSA-N n-methylquinoline-7-carboxamide Chemical compound C1=CC=NC2=CC(C(=O)NC)=CC=C21 GCJYRIRCTQDLJX-UHFFFAOYSA-N 0.000 claims 1
- AKVITZDRJGIFAS-UHFFFAOYSA-N n-propylmethanesulfonamide Chemical compound CCCNS(C)(=O)=O AKVITZDRJGIFAS-UHFFFAOYSA-N 0.000 claims 1
- 229940127084 other anti-cancer agent Drugs 0.000 claims 1
- PQPFFKCJENSZKL-UHFFFAOYSA-N pentan-3-amine Chemical compound CCC(N)CC PQPFFKCJENSZKL-UHFFFAOYSA-N 0.000 claims 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- RZAUIOKDXQWSQE-UHFFFAOYSA-N quinolin-7-amine Chemical compound C1=CC=NC2=CC(N)=CC=C21 RZAUIOKDXQWSQE-UHFFFAOYSA-N 0.000 claims 1
- WPYJKGWLDJECQD-UHFFFAOYSA-N quinoline-2-carbaldehyde Chemical compound C1=CC=CC2=NC(C=O)=CC=C21 WPYJKGWLDJECQD-UHFFFAOYSA-N 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract description 16
- 102000004887 Transforming Growth Factor beta Human genes 0.000 abstract description 15
- 108090001012 Transforming Growth Factor beta Proteins 0.000 abstract description 15
- 239000003112 inhibitor Substances 0.000 abstract description 3
- 230000019491 signal transduction Effects 0.000 abstract description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 206
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 167
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 136
- 239000000203 mixture Substances 0.000 description 132
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 105
- 238000002360 preparation method Methods 0.000 description 100
- 239000000243 solution Substances 0.000 description 97
- 238000000034 method Methods 0.000 description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 80
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 72
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 69
- 239000000047 product Substances 0.000 description 67
- 238000002531 positive electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 56
- 238000006243 chemical reaction Methods 0.000 description 53
- 239000007787 solid Substances 0.000 description 53
- 239000012141 concentrate Substances 0.000 description 45
- 235000008504 concentrate Nutrition 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 44
- 229910004298 SiO 2 Inorganic materials 0.000 description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 36
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 35
- 238000010992 reflux Methods 0.000 description 35
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 34
- 239000011541 reaction mixture Substances 0.000 description 33
- 239000002904 solvent Substances 0.000 description 33
- 239000012267 brine Substances 0.000 description 32
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 229910052938 sodium sulfate Inorganic materials 0.000 description 30
- 235000011152 sodium sulphate Nutrition 0.000 description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 29
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- 239000000126 substance Substances 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 21
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000009466 transformation Effects 0.000 description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 16
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 229960000583 acetic acid Drugs 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 14
- 238000000844 transformation Methods 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- 239000003054 catalyst Substances 0.000 description 11
- 125000000623 heterocyclic group Chemical group 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 229940098779 methanesulfonic acid Drugs 0.000 description 11
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 10
- 229910000024 caesium carbonate Inorganic materials 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 10
- 229910052763 palladium Inorganic materials 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 239000012312 sodium hydride Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 8
- 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- AJBPJQZDKCSHPT-UHFFFAOYSA-N 1-pyridin-2-yl-2-quinolin-4-ylethanone Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=O)C1=CC=CC=N1 AJBPJQZDKCSHPT-UHFFFAOYSA-N 0.000 description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 239000012038 nucleophile Substances 0.000 description 7
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 238000007363 ring formation reaction Methods 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 230000010933 acylation Effects 0.000 description 6
- 238000005917 acylation reaction Methods 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 229960001231 choline Drugs 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 150000004820 halides Chemical class 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- FEECKXSWEAITAQ-UHFFFAOYSA-N 3-benzyl-4-bromobutanoic acid Chemical compound OC(=O)CC(CBr)CC1=CC=CC=C1 FEECKXSWEAITAQ-UHFFFAOYSA-N 0.000 description 5
- YSXDKDWNIPOSMF-UHFFFAOYSA-N 5-chloropentanoic acid Chemical compound OC(=O)CCCCCl YSXDKDWNIPOSMF-UHFFFAOYSA-N 0.000 description 5
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 5
- KZRAAPTWXAMZHQ-UHFFFAOYSA-N methoxymethanamine Chemical compound COCN KZRAAPTWXAMZHQ-UHFFFAOYSA-N 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 239000008096 xylene Substances 0.000 description 5
- 229910052727 yttrium Inorganic materials 0.000 description 5
- KOPFEFZSAMLEHK-UHFFFAOYSA-N 1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1C=CNN=1 KOPFEFZSAMLEHK-UHFFFAOYSA-N 0.000 description 4
- IPLKGJHGWCVSOG-UHFFFAOYSA-N 4-chlorobutanoic acid Chemical compound OC(=O)CCCCl IPLKGJHGWCVSOG-UHFFFAOYSA-N 0.000 description 4
- LTUUGSGSUZRPRV-UHFFFAOYSA-N 6-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=CC(C(O)=O)=N1 LTUUGSGSUZRPRV-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 4
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 4
- 150000001345 alkine derivatives Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001502 aryl halides Chemical class 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 4
- 229910000105 potassium hydride Inorganic materials 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 150000003335 secondary amines Chemical class 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 4
- AHSKTUQHNZINQC-UHFFFAOYSA-N (1-pyridin-2-yl-2-quinolin-4-ylethylidene)hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC=N1 AHSKTUQHNZINQC-UHFFFAOYSA-N 0.000 description 3
- XBYRMPXUBGMOJC-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one Chemical compound OC=1C=CNN=1 XBYRMPXUBGMOJC-UHFFFAOYSA-N 0.000 description 3
- HMAHITRAFPEBFM-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=CC(F)=CC=2)=N1 HMAHITRAFPEBFM-UHFFFAOYSA-N 0.000 description 3
- ZNTYIKQTDNLOIZ-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-oxo-3-[6-(trifluoromethyl)pyridin-2-yl]propanenitrile Chemical compound C1=CC(F)=CC=C1C(C#N)C(=O)C1=CC=CC(C(F)(F)F)=N1 ZNTYIKQTDNLOIZ-UHFFFAOYSA-N 0.000 description 3
- LOMBYWOEYMBBGZ-UHFFFAOYSA-N 4,7-dimethylquinoline Chemical compound CC1=CC=NC2=CC(C)=CC=C21 LOMBYWOEYMBBGZ-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 3
- ZDNICFYNWASODE-UHFFFAOYSA-N chembl260147 Chemical compound C=1C=NC2=CC(O)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 ZDNICFYNWASODE-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229910000103 lithium hydride Inorganic materials 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 3
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000005493 quinolyl group Chemical group 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 3
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- JUBQVPQOFPPONI-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-naphthalen-2-ylethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=C3C=CC=CC3=CC=2)=N1 JUBQVPQOFPPONI-UHFFFAOYSA-N 0.000 description 2
- UFHMNJKABGHUOC-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-quinolin-6-ylethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=C3C=CC=NC3=CC=2)=N1 UFHMNJKABGHUOC-UHFFFAOYSA-N 0.000 description 2
- DHPPTIXDMSKLRM-UHFFFAOYSA-N 1-(benzhydrylideneamino)-4-(3-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC=CC(C2CC(=O)N(N=C(C=3C=CC=CC=3)C=3C=CC=CC=3)C2)=C1 DHPPTIXDMSKLRM-UHFFFAOYSA-N 0.000 description 2
- FUTKYPVWTIJNDA-UHFFFAOYSA-N 1-(benzhydrylideneamino)pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1C=CC=CC=1)C1=CC=CC=C1 FUTKYPVWTIJNDA-UHFFFAOYSA-N 0.000 description 2
- MBCICIRHFWCNAX-UHFFFAOYSA-N 1-(chloromethyl)-4-fluoronaphthalene Chemical compound C1=CC=C2C(F)=CC=C(CCl)C2=C1 MBCICIRHFWCNAX-UHFFFAOYSA-N 0.000 description 2
- DMHZDOTYAVHSEH-UHFFFAOYSA-N 1-(chloromethyl)-4-methylbenzene Chemical compound CC1=CC=C(CCl)C=C1 DMHZDOTYAVHSEH-UHFFFAOYSA-N 0.000 description 2
- YTXJCOIVRPVEHX-UHFFFAOYSA-N 1-[(1-pyridin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1N=CC=CC=1)CC1=CC=NC2=CC=CC=C12 YTXJCOIVRPVEHX-UHFFFAOYSA-N 0.000 description 2
- WFMYAMTVUUUBJN-UHFFFAOYSA-N 1-amino-4-(4-chlorophenyl)pyrrolidin-2-one Chemical compound C1C(=O)N(N)CC1C1=CC=C(Cl)C=C1 WFMYAMTVUUUBJN-UHFFFAOYSA-N 0.000 description 2
- MYKBXOQHDQLNGL-UHFFFAOYSA-N 1-methoxy-4-nitro-2-phenylmethoxybenzene Chemical compound COC1=CC=C([N+]([O-])=O)C=C1OCC1=CC=CC=C1 MYKBXOQHDQLNGL-UHFFFAOYSA-N 0.000 description 2
- PPFGQUJKFSPUQO-UHFFFAOYSA-N 1-pyridin-2-yl-2-quinolin-6-ylethanone Chemical compound C=1C=C2N=CC=CC2=CC=1CC(=O)C1=CC=CC=N1 PPFGQUJKFSPUQO-UHFFFAOYSA-N 0.000 description 2
- ARGCQEVBJHPOGB-UHFFFAOYSA-N 2,5-dihydrofuran Chemical compound C1OCC=C1 ARGCQEVBJHPOGB-UHFFFAOYSA-N 0.000 description 2
- FWJMGOSIXICDFN-UHFFFAOYSA-N 2-(4-fluoronaphthalen-1-yl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=CC=C3C(F)=CC=2)=N1 FWJMGOSIXICDFN-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- UODINHBLNPPDPD-UHFFFAOYSA-N 2-bromo-5-fluoropyridine Chemical compound FC1=CC=C(Br)N=C1 UODINHBLNPPDPD-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- RUFOVPQUNXLVFW-UHFFFAOYSA-N 2-ethynyl-6-methylpyridine Chemical compound CC1=CC=CC(C#C)=N1 RUFOVPQUNXLVFW-UHFFFAOYSA-N 0.000 description 2
- QYULGZFRXIJQAH-UHFFFAOYSA-N 2-naphthalen-2-yl-1-pyridin-2-ylethanone Chemical compound C=1C=C2C=CC=CC2=CC=1CC(=O)C1=CC=CC=N1 QYULGZFRXIJQAH-UHFFFAOYSA-N 0.000 description 2
- GUGQQGROXHPINL-UHFFFAOYSA-N 2-oxobutanoyl chloride Chemical compound CCC(=O)C(Cl)=O GUGQQGROXHPINL-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- BIZXOIBNWPRMIG-UHFFFAOYSA-N 2-pyridin-2-yl-3-quinolin-4-yl-6,7-dihydropyrazolo[5,1-c][1,4]oxazin-4-one Chemical compound C=1C=NC2=CC=CC=C2C=1C1=C2C(=O)OCCN2N=C1C1=CC=CC=N1 BIZXOIBNWPRMIG-UHFFFAOYSA-N 0.000 description 2
- DWGJOGHZZOLKFA-UHFFFAOYSA-N 2-quinolin-4-yl-1-(1,3-thiazol-2-yl)ethanone Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=O)C1=NC=CS1 DWGJOGHZZOLKFA-UHFFFAOYSA-N 0.000 description 2
- JYKXTMIYUCGJFZ-UHFFFAOYSA-N 3-(2-chloropyridin-4-yl)-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound C1=NC(Cl)=CC(C=2C(=NN3CCCC3=2)C=2N=CC=CC=2)=C1 JYKXTMIYUCGJFZ-UHFFFAOYSA-N 0.000 description 2
- RGWSXTLXRHYMOC-UHFFFAOYSA-N 3-(3-methoxyphenyl)-2h-furan-5-one Chemical compound COC1=CC=CC(C=2COC(=O)C=2)=C1 RGWSXTLXRHYMOC-UHFFFAOYSA-N 0.000 description 2
- NFYRRUONORBKNR-UHFFFAOYSA-N 3-(4-fluorophenyl)-2h-furan-5-one Chemical compound C1=CC(F)=CC=C1C1=CC(=O)OC1 NFYRRUONORBKNR-UHFFFAOYSA-N 0.000 description 2
- KEEGDIYRIATLIW-UHFFFAOYSA-N 3-(4-methylphenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound C1=CC(C)=CC=C1C(C(=N1)C=2N=C(C)C=CC=2)=C2N1CCC2 KEEGDIYRIATLIW-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- XMWHJMODTBOXDX-UHFFFAOYSA-N 4,5-dihydroxypentanoic acid Chemical compound OCC(O)CCC(O)=O XMWHJMODTBOXDX-UHFFFAOYSA-N 0.000 description 2
- KIQYQMCCZORPIM-UHFFFAOYSA-N 4-(3-methoxyphenyl)oxolan-2-one Chemical compound COC1=CC=CC(C2CC(=O)OC2)=C1 KIQYQMCCZORPIM-UHFFFAOYSA-N 0.000 description 2
- KOQBZUFDHPAUQA-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-methoxyoxolane Chemical compound C1OC(OC)CC1C1=CC=C(Cl)C=C1 KOQBZUFDHPAUQA-UHFFFAOYSA-N 0.000 description 2
- XGNXKDUZIZYHQQ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxolan-2-one Chemical compound C1=CC(F)=CC=C1C1CC(=O)OC1 XGNXKDUZIZYHQQ-UHFFFAOYSA-N 0.000 description 2
- XYOHCMYSMVSROW-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound C1=CC(Cl)=CC=C1C1=NN(CCCC2)C2=C1C1=CC=NC2=CC=CC=C12 XYOHCMYSMVSROW-UHFFFAOYSA-N 0.000 description 2
- IIPBUSYRAGAWNN-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-5-yl]benzoic acid Chemical compound CC1=CC=CC(C=2C(=C3CC(CN3N=2)C=2C=CC(=CC=2)C(O)=O)C=2C3=CC=CC=C3N=CC=2)=N1 IIPBUSYRAGAWNN-UHFFFAOYSA-N 0.000 description 2
- SRIWDROQQPUKBC-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-6-(trifluoromethoxy)quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(OC(F)(F)F)=CC=C3N=CC=2)=N1 SRIWDROQQPUKBC-UHFFFAOYSA-N 0.000 description 2
- PXJSURXYZLWKPA-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-6-(trifluoromethyl)quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(=CC=C3N=CC=2)C(F)(F)F)=N1 PXJSURXYZLWKPA-UHFFFAOYSA-N 0.000 description 2
- MVSAYZWMVLTVFT-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-7-phenylmethoxyquinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(OCC=4C=CC=CC=4)C=C3N=CC=2)=N1 MVSAYZWMVLTVFT-UHFFFAOYSA-N 0.000 description 2
- YLOIRLWCLAHZHK-UHFFFAOYSA-N 4-[2-[3-(trifluoromethoxy)phenyl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound FC(F)(F)OC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 YLOIRLWCLAHZHK-UHFFFAOYSA-N 0.000 description 2
- CTJGMUUFZXLFBF-UHFFFAOYSA-N 4-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 CTJGMUUFZXLFBF-UHFFFAOYSA-N 0.000 description 2
- ZNOUXOIZMNTERL-UHFFFAOYSA-N 4-benzoyloxolan-2-one Chemical compound C=1C=CC=CC=1C(=O)C1COC(=O)C1 ZNOUXOIZMNTERL-UHFFFAOYSA-N 0.000 description 2
- YKUMFVKVLCXLOE-UHFFFAOYSA-N 4-benzyloxolan-2-one Chemical compound C1OC(=O)CC1CC1=CC=CC=C1 YKUMFVKVLCXLOE-UHFFFAOYSA-N 0.000 description 2
- FLWGYWNGTJXZAG-UHFFFAOYSA-N 4-bromo-3-methylbutanoic acid Chemical compound BrCC(C)CC(O)=O FLWGYWNGTJXZAG-UHFFFAOYSA-N 0.000 description 2
- GIEDYTOIUIZWRO-UHFFFAOYSA-N 4-bromo-3-phenylbutanoic acid Chemical compound OC(=O)CC(CBr)C1=CC=CC=C1 GIEDYTOIUIZWRO-UHFFFAOYSA-N 0.000 description 2
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 2
- KMQLIDDEQAJAGJ-UHFFFAOYSA-N 4-oxo-4-phenylbutyric acid Chemical compound OC(=O)CCC(=O)C1=CC=CC=C1 KMQLIDDEQAJAGJ-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- ZLRZHWUEWCVYHG-UHFFFAOYSA-N 6-bromo-3h-quinolin-4-one Chemical compound N1=CCC(=O)C2=CC(Br)=CC=C21 ZLRZHWUEWCVYHG-UHFFFAOYSA-N 0.000 description 2
- WVFOQWQNCDNIEI-UHFFFAOYSA-N 6-ethylpyridine-2-carbonitrile Chemical compound CCC1=CC=CC(C#N)=N1 WVFOQWQNCDNIEI-UHFFFAOYSA-N 0.000 description 2
- LUYISICIYVKBTA-UHFFFAOYSA-N 6-methylquinoline Chemical compound N1=CC=CC2=CC(C)=CC=C21 LUYISICIYVKBTA-UHFFFAOYSA-N 0.000 description 2
- FDFCKUYJJATYBF-UHFFFAOYSA-N 6-propan-2-ylpyridine-2-carbonitrile Chemical compound CC(C)C1=CC=CC(C#N)=N1 FDFCKUYJJATYBF-UHFFFAOYSA-N 0.000 description 2
- KDGOODJXLHNGMS-UHFFFAOYSA-N 6-propan-2-ylpyridine-2-carboxylic acid Chemical compound CC(C)C1=CC=CC(C(O)=O)=N1 KDGOODJXLHNGMS-UHFFFAOYSA-N 0.000 description 2
- JOMRBZRNBUFJBZ-UHFFFAOYSA-N 6-propylpyridine-2-carbonitrile Chemical compound CCCC1=CC=CC(C#N)=N1 JOMRBZRNBUFJBZ-UHFFFAOYSA-N 0.000 description 2
- XOXHMQIQAGDQFI-UHFFFAOYSA-N 6-propylpyridine-2-carboxylic acid Chemical compound CCCC1=CC=CC(C(O)=O)=N1 XOXHMQIQAGDQFI-UHFFFAOYSA-N 0.000 description 2
- LVJHDVPCJRWNNZ-UHFFFAOYSA-N 7-methoxy-4-methylquinoline Chemical compound CC1=CC=NC2=CC(OC)=CC=C21 LVJHDVPCJRWNNZ-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 238000003512 Claisen condensation reaction Methods 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- WLKPHJWEIIAIFW-BYPYZUCNSA-N N-Nitrosoproline Chemical compound OC(=O)[C@@H]1CCCN1N=O WLKPHJWEIIAIFW-BYPYZUCNSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 108091005735 TGF-beta receptors Proteins 0.000 description 2
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium (II) Substances [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- QYCSNMDOZNUZIT-UHFFFAOYSA-N benzhydrylidenehydrazine Chemical compound C=1C=CC=CC=1C(=NN)C1=CC=CC=C1 QYCSNMDOZNUZIT-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 150000001642 boronic acid derivatives Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005810 carbonylation reaction Methods 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- JCWIWBWXCVGEAN-UHFFFAOYSA-L cyclopentyl(diphenyl)phosphane;dichloropalladium;iron Chemical compound [Fe].Cl[Pd]Cl.[CH]1[CH][CH][CH][C]1P(C=1C=CC=CC=1)C1=CC=CC=C1.[CH]1[CH][CH][CH][C]1P(C=1C=CC=CC=1)C1=CC=CC=C1 JCWIWBWXCVGEAN-UHFFFAOYSA-L 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- HCEFPBNJRNCSJW-UHFFFAOYSA-N ethyl 2-(6-methylpyridin-2-yl)propanoate Chemical compound C(C)OC(C(C)C1=NC(=CC=C1)C)=O HCEFPBNJRNCSJW-UHFFFAOYSA-N 0.000 description 2
- XSGSOGQWTLMFKT-UHFFFAOYSA-N ethyl 3-pyridin-2-yl-4-quinolin-4-yl-1h-pyrazole-5-carboxylate Chemical compound C=1C=NC2=CC=CC=C2C=1C=1C(C(=O)OCC)=NNC=1C1=CC=CC=N1 XSGSOGQWTLMFKT-UHFFFAOYSA-N 0.000 description 2
- WWLANXSQMRNEEG-UHFFFAOYSA-N ethyl 4-(2-pyridin-2-ylethynyl)quinoline-2-carboxylate Chemical compound C=12C=CC=CC2=NC(C(=O)OCC)=CC=1C#CC1=CC=CC=N1 WWLANXSQMRNEEG-UHFFFAOYSA-N 0.000 description 2
- WDSWOHLSQVMTPM-UHFFFAOYSA-N ethyl 4-(5-methoxyoxolan-3-yl)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1CC(OC)OC1 WDSWOHLSQVMTPM-UHFFFAOYSA-N 0.000 description 2
- FQYYIPZPELSLDK-UHFFFAOYSA-N ethyl pyridine-2-carboxylate Chemical compound CCOC(=O)C1=CC=CC=N1 FQYYIPZPELSLDK-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000002632 imidazolidinyl group Chemical group 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 2
- XQFRPMYFFLLZSB-UHFFFAOYSA-N methyl 4-acetyloxy-3-phenylbutanoate Chemical compound COC(=O)CC(COC(C)=O)C1=CC=CC=C1 XQFRPMYFFLLZSB-UHFFFAOYSA-N 0.000 description 2
- LKDXCLOPVCKKKS-UHFFFAOYSA-N methyl 5-phenyl-3-(phenylmethoxymethyl)pent-2-enoate Chemical compound C=1C=CC=CC=1COCC(=CC(=O)OC)CCC1=CC=CC=C1 LKDXCLOPVCKKKS-UHFFFAOYSA-N 0.000 description 2
- CYWIZMOZBTXFIL-UHFFFAOYSA-N methyl 6-methylpyridine-2-carboxylate Chemical compound COC(=O)C1=CC=CC(C)=N1 CYWIZMOZBTXFIL-UHFFFAOYSA-N 0.000 description 2
- ANNCINJMCFHILW-UHFFFAOYSA-N n-(benzhydrylideneamino)-4-chlorobutanamide Chemical compound C=1C=CC=CC=1C(=NNC(=O)CCCCl)C1=CC=CC=C1 ANNCINJMCFHILW-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 238000005897 peptide coupling reaction Methods 0.000 description 2
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 125000005545 phthalimidyl group Chemical group 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- KCBBEHBEAPOBSC-UHFFFAOYSA-N tert-butyl n-(2-amino-2-methylpropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC(C)(C)N KCBBEHBEAPOBSC-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 150000008648 triflates Chemical class 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PNIUSOFPFHQYDZ-UHFFFAOYSA-N (1-phenyl-2-quinolin-4-ylethylidene)hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC=C1 PNIUSOFPFHQYDZ-UHFFFAOYSA-N 0.000 description 1
- MFSQJHFHSQEGTI-UHFFFAOYSA-N (1-quinolin-2-yl-2-quinolin-4-ylethylidene)hydrazine Chemical compound N1=CC=C(C2=CC=CC=C12)CC(C1=NC2=CC=CC=C2C=C1)=NN MFSQJHFHSQEGTI-UHFFFAOYSA-N 0.000 description 1
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 1
- PJPDSEYHEHGLOH-UHFFFAOYSA-N (2,2-difluoro-1,3-benzodioxol-5-yl)methanol Chemical compound OCC1=CC=C2OC(F)(F)OC2=C1 PJPDSEYHEHGLOH-UHFFFAOYSA-N 0.000 description 1
- NYPFNJOTVWTWAF-UHFFFAOYSA-N (2-oxopyrrolidin-1-yl)azanium;chloride Chemical compound Cl.NN1CCCC1=O NYPFNJOTVWTWAF-UHFFFAOYSA-N 0.000 description 1
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
- AUPRBAZNUAKWOY-HWYAHNCWSA-N (3r)-1-(benzhydrylideneamino)-3-methyl-5-phenylmethoxypyrrolidin-2-one Chemical compound C([C@H](C(N1N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)C)C1OCC1=CC=CC=C1 AUPRBAZNUAKWOY-HWYAHNCWSA-N 0.000 description 1
- HOGMOQBFVZVIID-HSZRJFAPSA-N (4r)-n-(benzhydrylideneamino)-4-hydroxy-5-phenylmethoxypentanamide Chemical compound C([C@@H](O)COCC=1C=CC=CC=1)CC(=O)NN=C(C=1C=CC=CC=1)C1=CC=CC=C1 HOGMOQBFVZVIID-HSZRJFAPSA-N 0.000 description 1
- HOGMOQBFVZVIID-QHCPKHFHSA-N (4s)-n-(benzhydrylideneamino)-4-hydroxy-5-phenylmethoxypentanamide Chemical compound C([C@H](O)COCC=1C=CC=CC=1)CC(=O)NN=C(C=1C=CC=CC=1)C1=CC=CC=C1 HOGMOQBFVZVIID-QHCPKHFHSA-N 0.000 description 1
- KFQTWWLCSBFUEM-HSZRJFAPSA-N (5r)-1-[[2-(4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethylidene]amino]-5-(phenylmethoxymethyl)pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=CC(F)=CC=2)=NN2C(CC[C@@H]2COCC=2C=CC=CC=2)=O)=N1 KFQTWWLCSBFUEM-HSZRJFAPSA-N 0.000 description 1
- GGDHQGIUBOOURE-LLVKDONJSA-N (5r)-1-amino-5-(phenylmethoxymethyl)pyrrolidin-2-one Chemical compound C1CC(=O)N(N)[C@H]1COCC1=CC=CC=C1 GGDHQGIUBOOURE-LLVKDONJSA-N 0.000 description 1
- JVPPZBQIEINDEG-LLVKDONJSA-N (5r)-5-(phenylmethoxymethyl)oxolan-2-one Chemical compound O1C(=O)CC[C@@H]1COCC1=CC=CC=C1 JVPPZBQIEINDEG-LLVKDONJSA-N 0.000 description 1
- KFQTWWLCSBFUEM-QHCPKHFHSA-N (5s)-1-[[2-(4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethylidene]amino]-5-(phenylmethoxymethyl)pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=CC(F)=CC=2)=NN2C(CC[C@H]2COCC=2C=CC=CC=2)=O)=N1 KFQTWWLCSBFUEM-QHCPKHFHSA-N 0.000 description 1
- GGDHQGIUBOOURE-NSHDSACASA-N (5s)-1-amino-5-(phenylmethoxymethyl)pyrrolidin-2-one Chemical compound C1CC(=O)N(N)[C@@H]1COCC1=CC=CC=C1 GGDHQGIUBOOURE-NSHDSACASA-N 0.000 description 1
- NSISJFFVIMQBRN-BYPYZUCNSA-N (5s)-5-(hydroxymethyl)oxolan-2-one Chemical compound OC[C@@H]1CCC(=O)O1 NSISJFFVIMQBRN-BYPYZUCNSA-N 0.000 description 1
- JVPPZBQIEINDEG-NSHDSACASA-N (5s)-5-(phenylmethoxymethyl)oxolan-2-one Chemical compound O1C(=O)CC[C@H]1COCC1=CC=CC=C1 JVPPZBQIEINDEG-NSHDSACASA-N 0.000 description 1
- UWDJTGUBOOQHLM-QFIPXVFZSA-N (6s)-3-(4-fluorophenyl)-2-(6-methylpyridin-2-yl)-6-(phenylmethoxymethyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CC[C@@H](COCC=4C=CC=CC=4)N3N=2)C=2C=CC(F)=CC=2)=N1 UWDJTGUBOOQHLM-QFIPXVFZSA-N 0.000 description 1
- 239000001211 (E)-4-phenylbut-3-en-2-one Substances 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- CMHPUBKZZPSUIQ-UHFFFAOYSA-N 1,3-benzodioxol-5-ylboronic acid Chemical compound OB(O)C1=CC=C2OCOC2=C1 CMHPUBKZZPSUIQ-UHFFFAOYSA-N 0.000 description 1
- YZJHZGXUKMBLJC-UHFFFAOYSA-N 1-(1,8-naphthyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound C1=CC=NC2=NC(C(CC=3C4=CC=CC=C4N=CC=3)=O)=CC=C21 YZJHZGXUKMBLJC-UHFFFAOYSA-N 0.000 description 1
- MTBDOWIYWGDCLP-UHFFFAOYSA-N 1-(1-methylimidazol-2-yl)-2-quinolin-4-ylethanone Chemical compound CN1C=CN=C1C(=O)CC1=CC=NC2=CC=CC=C12 MTBDOWIYWGDCLP-UHFFFAOYSA-N 0.000 description 1
- ZDOYHCIRUPHUHN-UHFFFAOYSA-N 1-(2-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1Cl ZDOYHCIRUPHUHN-UHFFFAOYSA-N 0.000 description 1
- LPGLSWLRQGUZBS-UHFFFAOYSA-N 1-(2-fluorophenyl)-2-quinolin-4-ylethanone Chemical compound FC1=CC=CC=C1C(=O)CC1=CC=NC2=CC=CC=C12 LPGLSWLRQGUZBS-UHFFFAOYSA-N 0.000 description 1
- DYSMHRAWNNQNIH-UHFFFAOYSA-N 1-(3-fluorophenyl)-2-quinolin-4-ylethanone Chemical compound FC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=C1 DYSMHRAWNNQNIH-UHFFFAOYSA-N 0.000 description 1
- DCDBPRGEFUBZBZ-UHFFFAOYSA-N 1-(4-chloropyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound ClC1=CC=NC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=C1 DCDBPRGEFUBZBZ-UHFFFAOYSA-N 0.000 description 1
- AVLGIQNJKOVSDJ-UHFFFAOYSA-N 1-(4-fluorophenyl)-2-quinolin-4-ylethanone Chemical compound C1=CC(F)=CC=C1C(=O)CC1=CC=NC2=CC=CC=C12 AVLGIQNJKOVSDJ-UHFFFAOYSA-N 0.000 description 1
- SYRAOCAJAWWOCY-UHFFFAOYSA-N 1-(5-chloropyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound N1=CC(Cl)=CC=C1C(=O)CC1=CC=NC2=CC=CC=C12 SYRAOCAJAWWOCY-UHFFFAOYSA-N 0.000 description 1
- VUMHOHKIRMFDFG-UHFFFAOYSA-N 1-(6-chloropyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound ClC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=N1 VUMHOHKIRMFDFG-UHFFFAOYSA-N 0.000 description 1
- VRJBUXDYXGHTMF-UHFFFAOYSA-N 1-(6-ethylpyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound CCC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=N1 VRJBUXDYXGHTMF-UHFFFAOYSA-N 0.000 description 1
- KKQHIIYSGYMQBN-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-(2,4,5-trifluorophenyl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C(=CC(F)=C(F)C=2)F)=N1 KKQHIIYSGYMQBN-UHFFFAOYSA-N 0.000 description 1
- USWGUFMJTAUUSC-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-(4-methylsulfonylphenyl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=CC(=CC=2)S(C)(=O)=O)=N1 USWGUFMJTAUUSC-UHFFFAOYSA-N 0.000 description 1
- UKMJHSIJUYLGTB-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-[6-(trifluoromethoxy)quinolin-4-yl]ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC(OC(F)(F)F)=CC=C3N=CC=2)=N1 UKMJHSIJUYLGTB-UHFFFAOYSA-N 0.000 description 1
- FFZUNUMDJGRUFS-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-[6-(trifluoromethyl)quinolin-4-yl]ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC(=CC=C3N=CC=2)C(F)(F)F)=N1 FFZUNUMDJGRUFS-UHFFFAOYSA-N 0.000 description 1
- LLNMRUHNADSJIH-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-[7-(trifluoromethyl)quinolin-4-yl]ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=C(C=C3N=CC=2)C(F)(F)F)=N1 LLNMRUHNADSJIH-UHFFFAOYSA-N 0.000 description 1
- QSVVDWDFXBIOGF-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-naphthalen-1-ylethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=CC=C3C=CC=2)=N1 QSVVDWDFXBIOGF-UHFFFAOYSA-N 0.000 description 1
- ZPMUYXJBNPYCLU-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-pyridin-3-ylethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=NC=CC=2)=N1 ZPMUYXJBNPYCLU-UHFFFAOYSA-N 0.000 description 1
- RYBJNXHNLNYRDT-UHFFFAOYSA-N 1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=N1 RYBJNXHNLNYRDT-UHFFFAOYSA-N 0.000 description 1
- NOFDLCZGXPYFEJ-UHFFFAOYSA-N 1-(6-propylpyridin-2-yl)-2-quinolin-4-ylethanone Chemical compound CCCC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=N1 NOFDLCZGXPYFEJ-UHFFFAOYSA-N 0.000 description 1
- VQAKUELBBKTKEQ-UHFFFAOYSA-N 1-(benzhydrylideneamino)-3-benzylpyrrolidin-2-one Chemical compound C1CN(N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)C(=O)C1CC1=CC=CC=C1 VQAKUELBBKTKEQ-UHFFFAOYSA-N 0.000 description 1
- CUMATXBJACPDSG-UHFFFAOYSA-N 1-(benzhydrylideneamino)-3-ethylpyrrolidin-2-one Chemical compound O=C1C(CC)CCN1N=C(C=1C=CC=CC=1)C1=CC=CC=C1 CUMATXBJACPDSG-UHFFFAOYSA-N 0.000 description 1
- AFTUYRVSAYIDKN-UHFFFAOYSA-N 1-(benzhydrylideneamino)-4,4-dimethylpyrrolidin-2-one Chemical compound O=C1CC(C)(C)CN1N=C(C=1C=CC=CC=1)C1=CC=CC=C1 AFTUYRVSAYIDKN-UHFFFAOYSA-N 0.000 description 1
- WMIJINXUGTVWLZ-UHFFFAOYSA-N 1-(benzhydrylideneamino)-4-(4-chlorophenyl)pyrrolidin-2-one Chemical compound C1=CC(Cl)=CC=C1C1CC(=O)N(N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1 WMIJINXUGTVWLZ-UHFFFAOYSA-N 0.000 description 1
- BSPFQIVKGKOGOW-UHFFFAOYSA-N 1-(benzhydrylideneamino)-4-(4-fluorophenyl)pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1C1CC(=O)N(N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1 BSPFQIVKGKOGOW-UHFFFAOYSA-N 0.000 description 1
- AKIYMQOWWZDTKF-UHFFFAOYSA-N 1-(benzylideneamino)-3-methylpyrrolidin-2-one Chemical compound O=C1C(C)CCN1N=CC1=CC=CC=C1 AKIYMQOWWZDTKF-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- MFADGLGTFNYEPC-UHFFFAOYSA-N 1-[(1-phenyl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1C=CC=CC=1)CC1=CC=NC2=CC=CC=C12 MFADGLGTFNYEPC-UHFFFAOYSA-N 0.000 description 1
- UMIBZRROIMPPAP-UHFFFAOYSA-N 1-[(1-pyridin-2-yl-2-pyridin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1N=CC=CC=1)CC1=CC=NC=C1 UMIBZRROIMPPAP-UHFFFAOYSA-N 0.000 description 1
- LQSAUVUDRTVADJ-UHFFFAOYSA-N 1-[(1-quinolin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1N=C2C=CC=CC2=CC=1)CC1=CC=NC2=CC=CC=C12 LQSAUVUDRTVADJ-UHFFFAOYSA-N 0.000 description 1
- KVCZUDVRDBPYBL-UHFFFAOYSA-N 1-[(2-quinolin-4-yl-1-thiophen-2-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1SC=CC=1)CC1=CC=NC2=CC=CC=C12 KVCZUDVRDBPYBL-UHFFFAOYSA-N 0.000 description 1
- XVYVDOSQJBKSSF-UHFFFAOYSA-N 1-[2-fluoro-3-(trifluoromethyl)phenyl]-2-quinolin-4-ylethanone Chemical compound C1=CC=C(C(F)(F)F)C(F)=C1C(=O)CC1=CC=NC2=CC=CC=C12 XVYVDOSQJBKSSF-UHFFFAOYSA-N 0.000 description 1
- XUPRXNKRXCXQJO-UHFFFAOYSA-N 1-[3-[7-(2-chloroethoxy)quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-2-yl]-N-methylprop-1-en-1-amine Chemical compound ClCCOC1=CC=C2C(=CC=NC2=C1)C1=C2N(N=C1C(=CC)NC)CCC2 XUPRXNKRXCXQJO-UHFFFAOYSA-N 0.000 description 1
- QYCJUBFCXHGOFB-UHFFFAOYSA-N 1-[[1-(3-fluorophenyl)-2-(4-fluorophenyl)ethylidene]amino]pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1CC(C=1C=C(F)C=CC=1)=NN1C(=O)CCC1 QYCJUBFCXHGOFB-UHFFFAOYSA-N 0.000 description 1
- GRIQDEDQJUJBMT-UHFFFAOYSA-N 1-[[1-(3-fluorophenyl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound FC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=C1 GRIQDEDQJUJBMT-UHFFFAOYSA-N 0.000 description 1
- BFFXSJCXNGIDHS-UHFFFAOYSA-N 1-[[1-(4-fluorophenyl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1C(CC=1C2=CC=CC=C2N=CC=1)=NN1C(=O)CCC1 BFFXSJCXNGIDHS-UHFFFAOYSA-N 0.000 description 1
- KOHUXQBBHAKUQC-UHFFFAOYSA-N 1-[[1-(4-methyl-1,3-thiazol-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CSC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=N1 KOHUXQBBHAKUQC-UHFFFAOYSA-N 0.000 description 1
- MNYLXOFRXGVTQU-UHFFFAOYSA-N 1-[[1-(6-bromopyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound BrC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=N1 MNYLXOFRXGVTQU-UHFFFAOYSA-N 0.000 description 1
- ZLKSXLHXTYIQOQ-UHFFFAOYSA-N 1-[[1-(6-methylpyridin-2-yl)-2-(2,4,5-trifluorophenyl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C(=CC(F)=C(F)C=2)F)=NN2C(CCC2)=O)=N1 ZLKSXLHXTYIQOQ-UHFFFAOYSA-N 0.000 description 1
- HNLVSXFXRFOVLC-UHFFFAOYSA-N 1-[[1-(6-methylpyridin-2-yl)-2-[6-(trifluoromethoxy)quinolin-4-yl]ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C3=CC(OC(F)(F)F)=CC=C3N=CC=2)=NN2C(CCC2)=O)=N1 HNLVSXFXRFOVLC-UHFFFAOYSA-N 0.000 description 1
- ZKZIAKMVUPIBBJ-UHFFFAOYSA-N 1-[[1-(6-methylpyridin-2-yl)-2-[7-(trifluoromethyl)quinolin-4-yl]ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C3=CC=C(C=C3N=CC=2)C(F)(F)F)=NN2C(CCC2)=O)=N1 ZKZIAKMVUPIBBJ-UHFFFAOYSA-N 0.000 description 1
- DGOBNTCPWWWALQ-UHFFFAOYSA-N 1-[[1-(6-propan-2-ylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound CC(C)C1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=N1 DGOBNTCPWWWALQ-UHFFFAOYSA-N 0.000 description 1
- JLMGZQNYGRBFRT-UHFFFAOYSA-N 1-[[1-[4-fluoro-3-(trifluoromethyl)phenyl]-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1C(CC=1C2=CC=CC=C2N=CC=1)=NN1C(=O)CCC1 JLMGZQNYGRBFRT-UHFFFAOYSA-N 0.000 description 1
- SCKGOGKVCJSTRM-UHFFFAOYSA-N 1-[[2-(3,4-difluorophenyl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=C(F)C(F)=CC=2)=NN2C(CCC2)=O)=N1 SCKGOGKVCJSTRM-UHFFFAOYSA-N 0.000 description 1
- HVJXYMZPRBGKIR-UHFFFAOYSA-N 1-[[2-(4-fluorophenyl)-1-(4-methyl-1,3-thiazol-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CSC(C(CC=2C=CC(F)=CC=2)=NN2C(CCC2)=O)=N1 HVJXYMZPRBGKIR-UHFFFAOYSA-N 0.000 description 1
- KMOAMAHCXHAYGR-UHFFFAOYSA-N 1-[[2-(4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=CC(F)=CC=2)=NN2C(CCC2)=O)=N1 KMOAMAHCXHAYGR-UHFFFAOYSA-N 0.000 description 1
- VULIWHLDZOUDKV-UHFFFAOYSA-N 1-[[2-(4-fluorophenyl)-1-pyridin-2-ylethylidene]amino]pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1CC(C=1N=CC=CC=1)=NN1C(=O)CCC1 VULIWHLDZOUDKV-UHFFFAOYSA-N 0.000 description 1
- VYKYAMQWCPGWJR-UHFFFAOYSA-N 1-[[2-(4-methoxyphenyl)-1-pyridin-2-ylethylidene]amino]pyrrolidin-2-one Chemical compound C1=CC(OC)=CC=C1CC(C=1N=CC=CC=1)=NN1C(=O)CCC1 VYKYAMQWCPGWJR-UHFFFAOYSA-N 0.000 description 1
- UPFMNLYGRMSZMG-UHFFFAOYSA-N 1-[[2-(6,7-dimethoxyquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1CC(C=1N=C(C)C=CC=1)=NN1CCCC1=O UPFMNLYGRMSZMG-UHFFFAOYSA-N 0.000 description 1
- GFQBOWWTMNAAGU-UHFFFAOYSA-N 1-[[2-(6,8-dimethoxyquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound C12=CC(OC)=CC(OC)=C2N=CC=C1CC(C=1N=C(C)C=CC=1)=NN1CCCC1=O GFQBOWWTMNAAGU-UHFFFAOYSA-N 0.000 description 1
- WELNPERCLUGLPU-UHFFFAOYSA-N 1-[[2-(6-bromoquinolin-4-yl)-1-pyridin-2-ylethylidene]amino]pyrrolidin-2-one Chemical compound C12=CC(Br)=CC=C2N=CC=C1CC(C=1N=CC=CC=1)=NN1CCCC1=O WELNPERCLUGLPU-UHFFFAOYSA-N 0.000 description 1
- DBOOSUWFESSCSQ-UHFFFAOYSA-N 1-[[2-(7-methoxyquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound C=1C=NC2=CC(OC)=CC=C2C=1CC(C=1N=C(C)C=CC=1)=NN1CCCC1=O DBOOSUWFESSCSQ-UHFFFAOYSA-N 0.000 description 1
- LIPRBSJEQNXQOY-UHFFFAOYSA-N 1-[[2-(7-methoxyquinolin-4-yl)-1-pyridin-2-ylethylidene]amino]pyrrolidin-2-one Chemical compound C=1C=NC2=CC(OC)=CC=C2C=1CC(C=1N=CC=CC=1)=NN1CCCC1=O LIPRBSJEQNXQOY-UHFFFAOYSA-N 0.000 description 1
- WNEQFXZCWDRBFQ-UHFFFAOYSA-N 1-[[2-quinolin-4-yl-1-(1,3-thiazol-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound O=C1CCCN1N=C(C=1SC=CN=1)CC1=CC=NC2=CC=CC=C12 WNEQFXZCWDRBFQ-UHFFFAOYSA-N 0.000 description 1
- KTTRFPFQZDQFEX-UHFFFAOYSA-N 1-[[2-quinolin-4-yl-1-[3-(trifluoromethoxy)phenyl]ethylidene]amino]pyrrolidin-2-one Chemical compound FC(F)(F)OC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=C1 KTTRFPFQZDQFEX-UHFFFAOYSA-N 0.000 description 1
- OEJVCNNGPJMQAF-UHFFFAOYSA-N 1-[[2-quinolin-4-yl-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]pyrrolidin-2-one Chemical compound FC(F)(F)C1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2)=O)=C1 OEJVCNNGPJMQAF-UHFFFAOYSA-N 0.000 description 1
- ZDGWMKGCLAPUDN-UHFFFAOYSA-N 1-[[2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethylidene]amino]pyrrolidin-2-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C(CC=1C2=CC=CC=C2N=CC=1)=NN1C(=O)CCC1 ZDGWMKGCLAPUDN-UHFFFAOYSA-N 0.000 description 1
- DLPIHOUOQVJXJK-UHFFFAOYSA-N 1-amino-3-benzylpyrrolidin-2-one;hydrochloride Chemical compound Cl.O=C1N(N)CCC1CC1=CC=CC=C1 DLPIHOUOQVJXJK-UHFFFAOYSA-N 0.000 description 1
- ZFTUEICLHNKYLW-UHFFFAOYSA-N 1-amino-4,4-dimethylpyrrolidin-2-one Chemical compound CC1(C)CN(N)C(=O)C1 ZFTUEICLHNKYLW-UHFFFAOYSA-N 0.000 description 1
- ZKKFRIGTKBAJFL-UHFFFAOYSA-N 1-amino-4-(3-methoxyphenyl)pyrrolidin-2-one Chemical compound COC1=CC=CC(C2CC(=O)N(N)C2)=C1 ZKKFRIGTKBAJFL-UHFFFAOYSA-N 0.000 description 1
- AFRVUAGCPSXDOF-UHFFFAOYSA-N 1-amino-4-(4-fluorophenyl)pyrrolidin-2-one Chemical compound C1C(=O)N(N)CC1C1=CC=C(F)C=C1 AFRVUAGCPSXDOF-UHFFFAOYSA-N 0.000 description 1
- CWLKTJOTWITYSI-UHFFFAOYSA-N 1-fluoronaphthalene Chemical compound C1=CC=C2C(F)=CC=CC2=C1 CWLKTJOTWITYSI-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 description 1
- MIGOYSHSZSSZFS-UHFFFAOYSA-N 1-pyrazin-2-yl-2-quinolin-4-ylethanone Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=O)C1=CN=CC=N1 MIGOYSHSZSSZFS-UHFFFAOYSA-N 0.000 description 1
- WFLXZZLROLIHDZ-UHFFFAOYSA-N 1-pyridin-2-yl-2-pyridin-4-ylethanone Chemical compound C=1C=CC=NC=1C(=O)CC1=CC=NC=C1 WFLXZZLROLIHDZ-UHFFFAOYSA-N 0.000 description 1
- VWZLHXGKOPSAAZ-UHFFFAOYSA-N 1-quinolin-2-yl-2-quinolin-4-ylethanone Chemical compound C1=CC=CC2=NC(C(CC=3C4=CC=CC=C4N=CC=3)=O)=CC=C21 VWZLHXGKOPSAAZ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JZQKSMWFQQDDLO-UHFFFAOYSA-N 2-(2-chloropyridin-4-yl)-1-pyridin-2-ylethanone Chemical compound C1=NC(Cl)=CC(CC(=O)C=2N=CC=CC=2)=C1 JZQKSMWFQQDDLO-UHFFFAOYSA-N 0.000 description 1
- STADUADRBVHQSK-UHFFFAOYSA-N 2-(2-chloroquinolin-4-yl)-1-pyridin-2-ylethanone Chemical compound C=12C=CC=CC2=NC(Cl)=CC=1CC(=O)C1=CC=CC=N1 STADUADRBVHQSK-UHFFFAOYSA-N 0.000 description 1
- ORMSKVKQKNOZIS-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=C(F)C(F)=CC=2)=N1 ORMSKVKQKNOZIS-UHFFFAOYSA-N 0.000 description 1
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
- WLXDKOWLDGMXCP-UHFFFAOYSA-N 2-(3-chloro-4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=C(Cl)C(F)=CC=2)=N1 WLXDKOWLDGMXCP-UHFFFAOYSA-N 0.000 description 1
- GAUHFGRZXPVMQD-UHFFFAOYSA-N 2-(3-chloro-4-fluorophenyl)acetonitrile Chemical compound FC1=CC=C(CC#N)C=C1Cl GAUHFGRZXPVMQD-UHFFFAOYSA-N 0.000 description 1
- XEHVQNYZSMMIKP-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(2-methyl-3h-pyrrol-5-yl)ethanone Chemical compound C1C(C)=NC(C(=O)CC=2C=CC(F)=CC=2)=C1 XEHVQNYZSMMIKP-UHFFFAOYSA-N 0.000 description 1
- PPKTUXZCCQKRKW-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-[6-(trifluoromethyl)pyridin-2-yl]ethanone Chemical compound C1=CC(F)=CC=C1CC(=O)C1=CC=CC(C(F)(F)F)=N1 PPKTUXZCCQKRKW-UHFFFAOYSA-N 0.000 description 1
- BWASSZQNCXUTSB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-pyridin-2-ylethanone Chemical compound C1=CC(F)=CC=C1CC(=O)C1=CC=CC=N1 BWASSZQNCXUTSB-UHFFFAOYSA-N 0.000 description 1
- JHQBLYITVCBGTO-UHFFFAOYSA-N 2-(4-fluorophenyl)acetonitrile Chemical compound FC1=CC=C(CC#N)C=C1 JHQBLYITVCBGTO-UHFFFAOYSA-N 0.000 description 1
- VRBHYXRTVKMTDA-UHFFFAOYSA-N 2-(4-methoxyphenyl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound C1=CC(OC)=CC=C1CC(=O)C1=CC=CC(C)=N1 VRBHYXRTVKMTDA-UHFFFAOYSA-N 0.000 description 1
- FKCJMURCMKIULQ-UHFFFAOYSA-N 2-(4-methoxyphenyl)-3-(6-methylpyridin-2-yl)-3-oxopropanenitrile Chemical compound C1=CC(OC)=CC=C1C(C#N)C(=O)C1=CC=CC(C)=N1 FKCJMURCMKIULQ-UHFFFAOYSA-N 0.000 description 1
- SFWFEBXQACRQMF-UHFFFAOYSA-N 2-(4-methylsulfonylphenyl)acetonitrile Chemical compound CS(=O)(=O)C1=CC=C(CC#N)C=C1 SFWFEBXQACRQMF-UHFFFAOYSA-N 0.000 description 1
- KXIHRMCVFLFLHQ-UHFFFAOYSA-N 2-(6-bromoquinolin-4-yl)-1-pyridin-2-ylethanone Chemical compound C12=CC(Br)=CC=C2N=CC=C1CC(=O)C1=CC=CC=N1 KXIHRMCVFLFLHQ-UHFFFAOYSA-N 0.000 description 1
- ZTLDAMJAIJHLOQ-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-1-quinolin-4-ylethanone Chemical compound CC1=CC=CC(CC(=O)C=2C3=CC=CC=C3N=CC=2)=N1 ZTLDAMJAIJHLOQ-UHFFFAOYSA-N 0.000 description 1
- GKPCKZJRMAIODR-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2,4,5-trifluorophenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C(=CC(F)=C(F)C=2)F)=N1 GKPCKZJRMAIODR-UHFFFAOYSA-N 0.000 description 1
- LPPOTXQQGUWXPQ-UHFFFAOYSA-N 2-(7-bromoquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=C(Br)C=C3N=CC=2)=N1 LPPOTXQQGUWXPQ-UHFFFAOYSA-N 0.000 description 1
- BWQITVFHCQKHGA-UHFFFAOYSA-N 2-(7-bromoquinolin-4-yl)-1-pyridin-2-ylethanone Chemical compound C=1C=NC2=CC(Br)=CC=C2C=1CC(=O)C1=CC=CC=N1 BWQITVFHCQKHGA-UHFFFAOYSA-N 0.000 description 1
- MGROWDJXAQPFSM-UHFFFAOYSA-N 2-(7-chloroquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=C(Cl)C=C3N=CC=2)=N1 MGROWDJXAQPFSM-UHFFFAOYSA-N 0.000 description 1
- QAMVMIUESWGHKB-UHFFFAOYSA-N 2-(7-chloroquinolin-4-yl)-1-pyridin-2-ylethanone Chemical compound C=1C=NC2=CC(Cl)=CC=C2C=1CC(=O)C1=CC=CC=N1 QAMVMIUESWGHKB-UHFFFAOYSA-N 0.000 description 1
- CCPFLAMZDZBZDD-UHFFFAOYSA-N 2-(7-ethoxyquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound C=1C=NC2=CC(OCC)=CC=C2C=1CC(=O)C1=CC=CC(C)=N1 CCPFLAMZDZBZDD-UHFFFAOYSA-N 0.000 description 1
- MYSMBTRXFCAWHX-UHFFFAOYSA-N 2-(7-methoxyquinolin-4-yl)-1-pyridin-2-ylethanone Chemical compound C=1C=NC2=CC(OC)=CC=C2C=1CC(=O)C1=CC=CC=N1 MYSMBTRXFCAWHX-UHFFFAOYSA-N 0.000 description 1
- ANXFYXIPILPYLL-UHFFFAOYSA-N 2-(8-fluoroquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C3=CC=CC(F)=C3N=CC=2)=N1 ANXFYXIPILPYLL-UHFFFAOYSA-N 0.000 description 1
- DOEJDSZHAQGKIQ-UHFFFAOYSA-N 2-(dimethylamino)-n-[4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]acetamide Chemical compound C=1C=NC2=CC(NC(=O)CN(C)C)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 DOEJDSZHAQGKIQ-UHFFFAOYSA-N 0.000 description 1
- KXKCTSZYNCDFFG-UHFFFAOYSA-N 2-Methoxy-5-nitrophenol Chemical compound COC1=CC=C([N+]([O-])=O)C=C1O KXKCTSZYNCDFFG-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- XHURHBKUJQQFNT-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenyl]-1-(6-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CC(C(=O)CC=2C=C(C(F)=CC=2)C(F)(F)F)=N1 XHURHBKUJQQFNT-UHFFFAOYSA-N 0.000 description 1
- JDYCEJNOWVBMOL-UHFFFAOYSA-N 2-[5-(hydroxymethyl)-3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl]ethanol Chemical compound C=1C=NC2=CC=CC=C2C=1C1=C(CO)N(CCO)N=C1C1=CC=CC=N1 JDYCEJNOWVBMOL-UHFFFAOYSA-N 0.000 description 1
- SOHDPICLICFSOP-UHFFFAOYSA-N 2-bromo-6-methylpyridine Chemical compound CC1=CC=CC(Br)=N1 SOHDPICLICFSOP-UHFFFAOYSA-N 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- 125000006012 2-chloroethoxy group Chemical group 0.000 description 1
- NYACYQAOLUGJOF-UHFFFAOYSA-N 2-ethoxy-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=12C=CC=CC2=NC(OCC)=CC=1C1=C2CCCN2N=C1C1=CC=CC=N1 NYACYQAOLUGJOF-UHFFFAOYSA-N 0.000 description 1
- NHUBNHMFXQNNMV-UHFFFAOYSA-N 2-ethynylpyridine Chemical compound C#CC1=CC=CC=N1 NHUBNHMFXQNNMV-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical compound OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 1
- UJVKQQXEPKQLAX-UHFFFAOYSA-N 2-methyl-1,3-thiazol-4-one Chemical compound CC1=NC(=O)CS1 UJVKQQXEPKQLAX-UHFFFAOYSA-N 0.000 description 1
- NFNOAHXEQXMCGT-UHFFFAOYSA-N 2-phenylmethoxyacetaldehyde Chemical compound O=CCOCC1=CC=CC=C1 NFNOAHXEQXMCGT-UHFFFAOYSA-N 0.000 description 1
- MLTHAMUBBPBSGE-UHFFFAOYSA-N 2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound N=1N2CCCC2=CC=1C1=CC=CC=N1 MLTHAMUBBPBSGE-UHFFFAOYSA-N 0.000 description 1
- BZXOKTDBQOQIFI-UHFFFAOYSA-N 2-quinolin-4-yl-1-[3-(trifluoromethoxy)phenyl]ethanone Chemical compound FC(F)(F)OC1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=C1 BZXOKTDBQOQIFI-UHFFFAOYSA-N 0.000 description 1
- KEXKWYGRFAZVLV-UHFFFAOYSA-N 2-quinolin-4-yl-1-[3-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC=CC(C(=O)CC=2C3=CC=CC=C3N=CC=2)=C1 KEXKWYGRFAZVLV-UHFFFAOYSA-N 0.000 description 1
- OSEATGPRADZRND-UHFFFAOYSA-N 2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanone Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)CC1=CC=NC2=CC=CC=C12 OSEATGPRADZRND-UHFFFAOYSA-N 0.000 description 1
- SGSMUSDVKCMDGR-UHFFFAOYSA-N 2-quinolin-6-ylacetonitrile Chemical compound N1=CC=CC2=CC(CC#N)=CC=C21 SGSMUSDVKCMDGR-UHFFFAOYSA-N 0.000 description 1
- LGCYVLDNGBSOOW-UHFFFAOYSA-N 2H-benzotriazol-4-ol 1-hydroxybenzotriazole Chemical compound OC1=CC=CC2=C1N=NN2.C1=CC=C2N(O)N=NC2=C1 LGCYVLDNGBSOOW-UHFFFAOYSA-N 0.000 description 1
- VSVWLSCAEDQAFY-UHFFFAOYSA-N 3-(1-benzothiophen-2-yl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2SC3=CC=CC=C3C=2)=N1 VSVWLSCAEDQAFY-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- JQLXLCYSWMVCLC-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=C(F)C(F)=CC=2)=N1 JQLXLCYSWMVCLC-UHFFFAOYSA-N 0.000 description 1
- OWIVATDPENYJLZ-UHFFFAOYSA-N 3-(4-fluoronaphthalen-1-yl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3C(F)=CC=2)=N1 OWIVATDPENYJLZ-UHFFFAOYSA-N 0.000 description 1
- ASRLFBGOPXVFBZ-UHFFFAOYSA-N 3-(4-fluorophenyl)-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound C1=CC(F)=CC=C1C(C(=N1)C=2N=CC=CC=2)=C2N1CCC2 ASRLFBGOPXVFBZ-UHFFFAOYSA-N 0.000 description 1
- OIEYKUDSZQAUNO-UHFFFAOYSA-N 3-(4-fluorophenyl)-4-hydroxybutanoic acid Chemical compound OC(=O)CC(CO)C1=CC=C(F)C=C1 OIEYKUDSZQAUNO-UHFFFAOYSA-N 0.000 description 1
- BBGANEZZHNMZCL-UHFFFAOYSA-N 3-(4-fluorophenyl)-6-methylidene-2-(6-methylpyridin-2-yl)-4,5-dihydropyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCC(=C)N3N=2)C=2C=CC(F)=CC=2)=N1 BBGANEZZHNMZCL-UHFFFAOYSA-N 0.000 description 1
- SOAGPOPZDBBHMB-UHFFFAOYSA-N 3-(4-methoxyphenyl)-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound C1=CC(OC)=CC=C1C(C(=N1)C=2N=CC=CC=2)=C2N1CCC2 SOAGPOPZDBBHMB-UHFFFAOYSA-N 0.000 description 1
- QCTWXDAWBGEYBX-UHFFFAOYSA-N 3-(chloromethyl)pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCC(CCl)C1 QCTWXDAWBGEYBX-UHFFFAOYSA-N 0.000 description 1
- ALZLTHLQMAFAPA-UHFFFAOYSA-N 3-Methylbutyrolactone Chemical compound CC1COC(=O)C1 ALZLTHLQMAFAPA-UHFFFAOYSA-N 0.000 description 1
- GYICCMMPZVWEPW-UHFFFAOYSA-N 3-[4-fluoro-3-(trifluoromethyl)phenyl]-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C=C(C(F)=CC=2)C(F)(F)F)=N1 GYICCMMPZVWEPW-UHFFFAOYSA-N 0.000 description 1
- RGSXIEPDSATBMK-UHFFFAOYSA-N 3-benzyl-1-[[1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(C(CC=3C=CC=CC=3)CC2)=O)=N1 RGSXIEPDSATBMK-UHFFFAOYSA-N 0.000 description 1
- AEQSNVSJMRVULT-UHFFFAOYSA-N 3-benzyl-4-bromobutanoyl chloride Chemical compound ClC(=O)CC(CBr)CC1=CC=CC=C1 AEQSNVSJMRVULT-UHFFFAOYSA-N 0.000 description 1
- KCZRIVUKXMDJGZ-UHFFFAOYSA-N 3-ethyl-1-[[1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound O=C1C(CC)CCN1N=C(C=1N=C(C)C=CC=1)CC1=CC=NC2=CC=CC=C12 KCZRIVUKXMDJGZ-UHFFFAOYSA-N 0.000 description 1
- MXNBDFWNYRNIBH-UHFFFAOYSA-N 3-fluorobenzoic acid Chemical compound OC(=O)C1=CC=CC(F)=C1 MXNBDFWNYRNIBH-UHFFFAOYSA-N 0.000 description 1
- GRYDWYUKBOFHEE-UHFFFAOYSA-N 3-methyl-1-[[pyridin-2-yl(quinolin-4-yl)methylidene]amino]pyrrolidin-2-one Chemical compound O=C1C(C)CCN1N=C(C=1C2=CC=CC=C2N=CC=1)C1=CC=CC=N1 GRYDWYUKBOFHEE-UHFFFAOYSA-N 0.000 description 1
- ZRXHLJNBNWVNIM-UHFFFAOYSA-N 3-methyl-1-benzofuran Chemical compound C1=CC=C2C(C)=COC2=C1 ZRXHLJNBNWVNIM-UHFFFAOYSA-N 0.000 description 1
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 1
- AOCWQPKHSMJWPL-UHFFFAOYSA-N 3-methylpyrrolidin-2-one Chemical compound CC1CCNC1=O AOCWQPKHSMJWPL-UHFFFAOYSA-N 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- IDHRHHLXBFGLSE-UHFFFAOYSA-N 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine Chemical class C1CCCN2N=CC=C21 IDHRHHLXBFGLSE-UHFFFAOYSA-N 0.000 description 1
- MVUJEDSVBFWAID-UHFFFAOYSA-N 4-(2-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)quinoline Chemical compound C=1C=NC2=CC=CC=C2C=1C1=C2CCCCN2N=C1C1=CC=CC=C1 MVUJEDSVBFWAID-UHFFFAOYSA-N 0.000 description 1
- DQXHHSPCCIUBPQ-UHFFFAOYSA-N 4-(2-phenylethyl)oxolan-2-one Chemical compound C1OC(=O)CC1CCC1=CC=CC=C1 DQXHHSPCCIUBPQ-UHFFFAOYSA-N 0.000 description 1
- JXGHHJQETWYELK-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-2-pyrrolidin-1-ylquinoline Chemical compound C1CCCN1C1=CC(C=2C(=NN3CCCC3=2)C=2N=CC=CC=2)=C(C=CC=C2)C2=N1 JXGHHJQETWYELK-UHFFFAOYSA-N 0.000 description 1
- ISKWDXAJTXOEMH-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-7-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propoxy]quinoline Chemical compound C1CN(C=2N=CC=CN=2)CCN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 ISKWDXAJTXOEMH-UHFFFAOYSA-N 0.000 description 1
- PYBNNQDPHWYXCF-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)-7-[3-(pyridin-2-ylmethylsulfanyl)propoxy]quinoline Chemical compound C=1C=CC=NC=1CSCCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 PYBNNQDPHWYXCF-UHFFFAOYSA-N 0.000 description 1
- AOTADNCHLKUEAX-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 AOTADNCHLKUEAX-UHFFFAOYSA-N 0.000 description 1
- VKHKIPOKKGDFFP-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbohydrazide Chemical compound C12=CC(C(=O)NN)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 VKHKIPOKKGDFFP-UHFFFAOYSA-N 0.000 description 1
- UGOMRXQHKZAZQT-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide Chemical compound C12=CC(C(=O)N)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 UGOMRXQHKZAZQT-UHFFFAOYSA-N 0.000 description 1
- PRQIAJGPZVCCGF-UHFFFAOYSA-N 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carbohydrazide Chemical compound C=1C=NC2=CC(C(=O)NN)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 PRQIAJGPZVCCGF-UHFFFAOYSA-N 0.000 description 1
- IYCVWKLNHCWIEH-UHFFFAOYSA-N 4-(2-pyridin-2-ylethynyl)quinoline Chemical compound N1=CC=CC=C1C#CC1=CC=NC2=CC=CC=C12 IYCVWKLNHCWIEH-UHFFFAOYSA-N 0.000 description 1
- RXQZTAPUJCECGC-UHFFFAOYSA-N 4-(3-ethoxyphenyl)-1-[(1-pyridin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound CCOc1cccc(c1)C1CN(N=C(Cc2ccnc3ccccc23)c2ccccn2)C(=O)C1 RXQZTAPUJCECGC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NOZZOMBUIIFXET-UHFFFAOYSA-N 4-(4-chlorophenyl)-1-[[2-(4-fluorophenyl)-1-(6-methylpyridin-2-yl)ethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C=CC(F)=CC=2)=NN2C(CC(C2)C=2C=CC(Cl)=CC=2)=O)=N1 NOZZOMBUIIFXET-UHFFFAOYSA-N 0.000 description 1
- FJIIHITUMSUKIQ-UHFFFAOYSA-N 4-(4-chlorophenyl)oxolan-2-one Chemical compound C1=CC(Cl)=CC=C1C1CC(=O)OC1 FJIIHITUMSUKIQ-UHFFFAOYSA-N 0.000 description 1
- WMEMSUSHVMWOHX-UHFFFAOYSA-N 4-(4-fluorophenyl)-1-[(1-pyridin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1C1CC(=O)N(N=C(CC=2C3=CC=CC=C3N=CC=2)C=2N=CC=CC=2)C1 WMEMSUSHVMWOHX-UHFFFAOYSA-N 0.000 description 1
- XTPHNPAFGIULNM-UHFFFAOYSA-N 4-(4-fluorophenyl)-1-[[1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CC(C2)C=2C=CC(F)=CC=2)=O)=N1 XTPHNPAFGIULNM-UHFFFAOYSA-N 0.000 description 1
- YGQYBXCXPFEDSP-UHFFFAOYSA-N 4-(5-methyl-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound N=1N2CC(C)CC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 YGQYBXCXPFEDSP-UHFFFAOYSA-N 0.000 description 1
- VYXZUYHURHIKSF-UHFFFAOYSA-N 4-(5-phenyl-2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC=CC=C2C=1C1=C2CC(C=3C=CC=CC=3)CN2N=C1C1=CC=CC=N1 VYXZUYHURHIKSF-UHFFFAOYSA-N 0.000 description 1
- JIDAHYHCQJXNTD-UHFFFAOYSA-N 4-(hydrazinecarbonyl)benzenesulfonamide Chemical compound NNC(=O)C1=CC=C(S(N)(=O)=O)C=C1 JIDAHYHCQJXNTD-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- ONFVORWGVPPBPG-UHFFFAOYSA-N 4-[2-(2-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound FC1=CC=CC=C1C1=NN(CCCC2)C2=C1C1=CC=NC2=CC=CC=C12 ONFVORWGVPPBPG-UHFFFAOYSA-N 0.000 description 1
- JJKRLAFJPHBSSV-UHFFFAOYSA-N 4-[2-(3-fluorophenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound FC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 JJKRLAFJPHBSSV-UHFFFAOYSA-N 0.000 description 1
- MNKPVYILICVZFW-UHFFFAOYSA-N 4-[2-(4-ethylpyridin-2-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound CCC1=CC=NC(C=2C(=C3CCCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 MNKPVYILICVZFW-UHFFFAOYSA-N 0.000 description 1
- GPIBQWUTNYLBTI-UHFFFAOYSA-N 4-[2-(6-benzylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C=1C=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=NC=1CC1=CC=CC=C1 GPIBQWUTNYLBTI-UHFFFAOYSA-N 0.000 description 1
- IZDBQLPBYWPNAN-UHFFFAOYSA-N 4-[2-(6-chloropyridin-2-yl)-5-(4-fluorophenyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1=CC(F)=CC=C1C1CN2N=C(C=3N=C(Cl)C=CC=3)C(C=3C4=CC=CC=C4N=CC=3)=C2C1 IZDBQLPBYWPNAN-UHFFFAOYSA-N 0.000 description 1
- MLTKRSQINDBPPX-UHFFFAOYSA-N 4-[2-(6-ethenylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C=CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 MLTKRSQINDBPPX-UHFFFAOYSA-N 0.000 description 1
- WGALZWWKJHCIBC-UHFFFAOYSA-N 4-[2-(6-ethylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CCC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 WGALZWWKJHCIBC-UHFFFAOYSA-N 0.000 description 1
- MSJLAIAIISFFOQ-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-6-phenylquinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC(=CC=C3N=CC=2)C=2C=CC=CC=2)=N1 MSJLAIAIISFFOQ-UHFFFAOYSA-N 0.000 description 1
- KAWGEVXPRPZBGU-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]-7-(trifluoromethyl)quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(C=C3N=CC=2)C(F)(F)F)=N1 KAWGEVXPRPZBGU-UHFFFAOYSA-N 0.000 description 1
- BFOOGGLTFKYHPN-UHFFFAOYSA-N 4-[2-(6-pyrrolidin-1-ylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1CCCN1C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 BFOOGGLTFKYHPN-UHFFFAOYSA-N 0.000 description 1
- RVIKVEDDHOOCSX-UHFFFAOYSA-N 4-[2-(furan-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CO1 RVIKVEDDHOOCSX-UHFFFAOYSA-N 0.000 description 1
- KPPUUADUSZBXNL-UHFFFAOYSA-N 4-[2-[3-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl]quinoline Chemical compound FC(F)(F)C1=CC=CC(C=2C(=C3CCCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=C1 KPPUUADUSZBXNL-UHFFFAOYSA-N 0.000 description 1
- RHLPERPPZRGNJD-UHFFFAOYSA-N 4-[2-[6-(4-methoxyphenyl)pyridin-2-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C1=CC(OC)=CC=C1C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 RHLPERPPZRGNJD-UHFFFAOYSA-N 0.000 description 1
- IKSJFKVQYSHQET-UHFFFAOYSA-N 4-[4-(2-benzhydrylidenehydrazinyl)-1-hydroxy-4-oxobutan-2-yl]benzoic acid Chemical compound C(C1=CC=CC=C1)(C1=CC=CC=C1)=NNC(=O)CC(CO)C1=CC=C(C(=O)O)C=C1 IKSJFKVQYSHQET-UHFFFAOYSA-N 0.000 description 1
- FXAXKYAUNGXDFO-UHFFFAOYSA-N 4-[6-(3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)pyridin-2-yl]morpholine Chemical compound N=1N2CCCC2=C(C=2C3=CC=CC=C3N=CC=2)C=1C(N=1)=CC=CC=1N1CCOCC1 FXAXKYAUNGXDFO-UHFFFAOYSA-N 0.000 description 1
- LPPVNDXVKOYJNC-UHFFFAOYSA-N 4-[6-(phenylmethoxymethyl)-2-pyridin-2-yl-4,5-dihydropyrrolo[1,2-b]pyrazol-6-yl]quinoline Chemical compound C=1C=CC=CC=1COCC(N1N=2)(C=3C4=CC=CC=C4N=CC=3)CCC1=CC=2C1=CC=CC=N1 LPPVNDXVKOYJNC-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WBUSTPLHDDHPAI-UHFFFAOYSA-N 4-benzyl-1-[(1-pyridin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound C1N(N=C(CC=2C3=CC=CC=C3N=CC=2)C=2N=CC=CC=2)C(=O)CC1CC1=CC=CC=C1 WBUSTPLHDDHPAI-UHFFFAOYSA-N 0.000 description 1
- JYJMGOHVUNJGEP-UHFFFAOYSA-N 4-bromo-n-[(1-pyrazin-2-yl-2-quinolin-4-ylethylidene)amino]butanamide Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NNC(=O)CCCBr)C1=CN=CC=N1 JYJMGOHVUNJGEP-UHFFFAOYSA-N 0.000 description 1
- OCPCDZBJOHJNQJ-UHFFFAOYSA-N 4-bromopiperidine-1-carboxylic acid Chemical compound OC(=O)N1CCC(Br)CC1 OCPCDZBJOHJNQJ-UHFFFAOYSA-N 0.000 description 1
- PCXDJUKJQGARIP-UHFFFAOYSA-N 4-chloro-N-[[1-[2-fluoro-3-(trifluoromethyl)phenyl]-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound FC1=C(C=CC=C1C(F)(F)F)C(CC1=CC=NC2=CC=CC=C12)=NNC(CCCCl)=O PCXDJUKJQGARIP-UHFFFAOYSA-N 0.000 description 1
- FABHSAZHUGXDBI-UHFFFAOYSA-N 4-chloro-n-[(1-quinolin-2-yl-2-quinolin-4-ylethylidene)amino]butanamide Chemical compound C1=CC=CC2=NC(C(CC=3C4=CC=CC=C4N=CC=3)=NNC(=O)CCCCl)=CC=C21 FABHSAZHUGXDBI-UHFFFAOYSA-N 0.000 description 1
- OCTVXQKANDHZSI-UHFFFAOYSA-N 4-chloro-n-[[1-(2-fluorophenyl)-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound FC1=CC=CC=C1C(=NNC(=O)CCCCl)CC1=CC=NC2=CC=CC=C12 OCTVXQKANDHZSI-UHFFFAOYSA-N 0.000 description 1
- UDZGCSAXJGVTAV-UHFFFAOYSA-N 4-chloro-n-[[1-(3-fluorophenyl)-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound FC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCl)=C1 UDZGCSAXJGVTAV-UHFFFAOYSA-N 0.000 description 1
- KBMHTUIPPGWXBQ-UHFFFAOYSA-N 4-chloro-n-[[1-(4-chloropyridin-2-yl)-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NNC(=O)CCCCl)C1=CC(Cl)=CC=N1 KBMHTUIPPGWXBQ-UHFFFAOYSA-N 0.000 description 1
- MXKRYCMQZRLZQL-UHFFFAOYSA-N 4-chloro-n-[[1-(4-fluorophenyl)-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound C1=CC(F)=CC=C1C(=NNC(=O)CCCCl)CC1=CC=NC2=CC=CC=C12 MXKRYCMQZRLZQL-UHFFFAOYSA-N 0.000 description 1
- CSFIDZOYIHRYMO-UHFFFAOYSA-N 4-chloro-n-[[1-(6-chloropyridin-2-yl)-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NNC(=O)CCCCl)C1=CC=CC(Cl)=N1 CSFIDZOYIHRYMO-UHFFFAOYSA-N 0.000 description 1
- BZOFAQIPGKUKPZ-UHFFFAOYSA-N 4-chloro-n-[[1-[3-fluoro-5-(trifluoromethyl)phenyl]-2-quinolin-4-ylethylidene]amino]butanamide Chemical compound FC(F)(F)C1=CC(F)=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCl)=C1 BZOFAQIPGKUKPZ-UHFFFAOYSA-N 0.000 description 1
- HOVXWKUKZMWAJK-UHFFFAOYSA-N 4-chloro-n-[[2-(6,8-dimethoxyquinolin-4-yl)-1-pyridin-2-ylethylidene]amino]butanamide Chemical compound C12=CC(OC)=CC(OC)=C2N=CC=C1CC(=NNC(=O)CCCCl)C1=CC=CC=N1 HOVXWKUKZMWAJK-UHFFFAOYSA-N 0.000 description 1
- FXJZIYJWLIVOFY-UHFFFAOYSA-N 4-chloro-n-[[2-quinolin-4-yl-1-[3-(trifluoromethoxy)phenyl]ethylidene]amino]butanamide Chemical compound FC(F)(F)OC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCl)=C1 FXJZIYJWLIVOFY-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- CDIIZULDSLKBKV-UHFFFAOYSA-N 4-chlorobutanoyl chloride Chemical compound ClCCCC(Cl)=O CDIIZULDSLKBKV-UHFFFAOYSA-N 0.000 description 1
- WZBPZYCJUADXRS-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(F)C(C(F)(F)F)=C1 WZBPZYCJUADXRS-UHFFFAOYSA-N 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- KGIUNFQRWJLBSV-UHFFFAOYSA-N 4-hydroxy-3-(3-methoxyphenyl)butanoic acid Chemical compound COC1=CC=CC(C(CO)CC(O)=O)=C1 KGIUNFQRWJLBSV-UHFFFAOYSA-N 0.000 description 1
- LIZSTFVNADZHIS-UHFFFAOYSA-N 4-methyl-1-[(1-pyridin-2-yl-2-quinolin-4-ylethylidene)amino]pyrrolidin-2-one Chemical compound O=C1CC(C)CN1N=C(C=1N=CC=CC=1)CC1=CC=NC2=CC=CC=C12 LIZSTFVNADZHIS-UHFFFAOYSA-N 0.000 description 1
- JAUYSFJDHYRUCF-UHFFFAOYSA-N 4-methyl-6-(trifluoromethoxy)quinoline Chemical compound C1=C(OC(F)(F)F)C=C2C(C)=CC=NC2=C1 JAUYSFJDHYRUCF-UHFFFAOYSA-N 0.000 description 1
- IWXOLSNPKOMLCH-UHFFFAOYSA-N 4-methyl-7-(trifluoromethyl)quinoline Chemical compound FC(F)(F)C1=CC=C2C(C)=CC=NC2=C1 IWXOLSNPKOMLCH-UHFFFAOYSA-N 0.000 description 1
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 1
- OCUVISZQCCNAME-UHFFFAOYSA-N 4-phenyl-1-phenylmethoxybutan-2-ol Chemical compound C=1C=CC=CC=1COCC(O)CCC1=CC=CC=C1 OCUVISZQCCNAME-UHFFFAOYSA-N 0.000 description 1
- WEKFCYVZDNGKJY-UHFFFAOYSA-N 4-phenyl-1-phenylmethoxybutan-2-one Chemical compound C=1C=CC=CC=1COCC(=O)CCC1=CC=CC=C1 WEKFCYVZDNGKJY-UHFFFAOYSA-N 0.000 description 1
- YFNSPPHTAARSPD-UHFFFAOYSA-N 4-phenyloxolan-2-one Chemical compound C1OC(=O)CC1C1=CC=CC=C1 YFNSPPHTAARSPD-UHFFFAOYSA-N 0.000 description 1
- TWIROCHBZRSMEC-UHFFFAOYSA-N 5-(chloromethyl)-2,2-difluoro-1,3-benzodioxole Chemical compound C1=C(CCl)C=C2OC(F)(F)OC2=C1 TWIROCHBZRSMEC-UHFFFAOYSA-N 0.000 description 1
- KBTSJVTVHPTSHY-UHFFFAOYSA-N 5-(hydroxymethyl)-1-[[1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pyrrolidin-2-one Chemical compound CC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN2C(CCC2CO)=O)=N1 KBTSJVTVHPTSHY-UHFFFAOYSA-N 0.000 description 1
- HVLLNMYRCFIOEJ-UHFFFAOYSA-N 5-chloro-n-[[1-(1,8-naphthyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound C1=CC=NC2=NC(C(CC=3C4=CC=CC=C4N=CC=3)=NNC(=O)CCCCCl)=CC=C21 HVLLNMYRCFIOEJ-UHFFFAOYSA-N 0.000 description 1
- MIWVNKUWJMOGOE-UHFFFAOYSA-N 5-chloro-n-[[1-(2-fluorophenyl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound FC1=CC=CC=C1C(=NNC(=O)CCCCCl)CC1=CC=NC2=CC=CC=C12 MIWVNKUWJMOGOE-UHFFFAOYSA-N 0.000 description 1
- OTOUZDYGLILSTI-UHFFFAOYSA-N 5-chloro-n-[[1-(3-chlorophenyl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NNC(=O)CCCCCl)C1=CC=CC(Cl)=C1 OTOUZDYGLILSTI-UHFFFAOYSA-N 0.000 description 1
- UTCNAWNULZDKEE-UHFFFAOYSA-N 5-chloro-n-[[1-(4-chlorophenyl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NNC(=O)CCCCCl)C1=CC=C(Cl)C=C1 UTCNAWNULZDKEE-UHFFFAOYSA-N 0.000 description 1
- WYUFIQXXCDGGSK-UHFFFAOYSA-N 5-chloro-n-[[1-(4-ethylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound CCC1=CC=NC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCCl)=C1 WYUFIQXXCDGGSK-UHFFFAOYSA-N 0.000 description 1
- FHQNUZHUWJCIFP-UHFFFAOYSA-N 5-chloro-n-[[1-(4-fluorophenyl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound C1=CC(F)=CC=C1C(=NNC(=O)CCCCCl)CC1=CC=NC2=CC=CC=C12 FHQNUZHUWJCIFP-UHFFFAOYSA-N 0.000 description 1
- JUVXGTMPLZRGIG-UHFFFAOYSA-N 5-chloro-n-[[1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound CC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCCl)=N1 JUVXGTMPLZRGIG-UHFFFAOYSA-N 0.000 description 1
- HIWYNOPSAJSSGK-UHFFFAOYSA-N 5-chloro-n-[[1-[3-fluoro-5-(trifluoromethyl)phenyl]-2-quinolin-4-ylethylidene]amino]pentanamide Chemical compound FC(F)(F)C1=CC(F)=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCCl)=C1 HIWYNOPSAJSSGK-UHFFFAOYSA-N 0.000 description 1
- KGWXEFSWXRHNFQ-UHFFFAOYSA-N 5-chloro-n-[[2-quinolin-4-yl-1-[3-(trifluoromethoxy)phenyl]ethylidene]amino]pentanamide Chemical compound FC(F)(F)OC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NNC(=O)CCCCCl)=C1 KGWXEFSWXRHNFQ-UHFFFAOYSA-N 0.000 description 1
- YJTXQLYMECWULH-UHFFFAOYSA-N 5-fluoropyridin-2-amine Chemical compound NC1=CC=C(F)C=N1 YJTXQLYMECWULH-UHFFFAOYSA-N 0.000 description 1
- VGZHFXHVAWBZMW-UHFFFAOYSA-N 6,7-dichloro-4-methylquinoline Chemical compound ClC1=C(Cl)C=C2C(C)=CC=NC2=C1 VGZHFXHVAWBZMW-UHFFFAOYSA-N 0.000 description 1
- KCJOGOXWRZOKIH-UHFFFAOYSA-N 6,7-difluoro-4-methylquinoline Chemical compound FC1=C(F)C=C2C(C)=CC=NC2=C1 KCJOGOXWRZOKIH-UHFFFAOYSA-N 0.000 description 1
- RKGJUDFCBXVRHJ-UHFFFAOYSA-N 6,7-dimethoxy-4-methylquinoline Chemical compound C1=CC(C)=C2C=C(OC)C(OC)=CC2=N1 RKGJUDFCBXVRHJ-UHFFFAOYSA-N 0.000 description 1
- ZCTKDDFPWGHPQF-UHFFFAOYSA-N 6,8-dimethoxy-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound C12=CC(OC)=CC(OC)=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 ZCTKDDFPWGHPQF-UHFFFAOYSA-N 0.000 description 1
- ZLJHXFORYMASCB-UHFFFAOYSA-N 6-(3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)pyridine-2-carboxamide Chemical compound NC(=O)C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 ZLJHXFORYMASCB-UHFFFAOYSA-N 0.000 description 1
- FTOWKSWJLZAFRC-UHFFFAOYSA-N 6-(3-quinolin-4-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-2-yl)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=CC=C3N=CC=2)=N1 FTOWKSWJLZAFRC-UHFFFAOYSA-N 0.000 description 1
- UEQUKTBVFCILAS-UHFFFAOYSA-N 6-(trifluoromethyl)pyridine-2-carbothioic S-acid Chemical compound FC(F)(F)C1=CC=CC(C(S)=O)=N1 UEQUKTBVFCILAS-UHFFFAOYSA-N 0.000 description 1
- IBVWKPKFYZDRFF-UHFFFAOYSA-N 6-bromo-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C12=CC(Br)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 IBVWKPKFYZDRFF-UHFFFAOYSA-N 0.000 description 1
- XBZQSJLYRMZRSZ-UHFFFAOYSA-N 6-bromo-4-methylquinoline Chemical compound C1=C(Br)C=C2C(C)=CC=NC2=C1 XBZQSJLYRMZRSZ-UHFFFAOYSA-N 0.000 description 1
- XSSPRYGYLWAQOR-UHFFFAOYSA-N 6-chloro-n-methoxy-n-methylpyridine-2-carboxamide Chemical compound CON(C)C(=O)C1=CC=CC(Cl)=N1 XSSPRYGYLWAQOR-UHFFFAOYSA-N 0.000 description 1
- DHEWXSFEYYRAOQ-UHFFFAOYSA-N 6-ethoxy-4-methylquinoline Chemical compound N1=CC=C(C)C2=CC(OCC)=CC=C21 DHEWXSFEYYRAOQ-UHFFFAOYSA-N 0.000 description 1
- PKCFVDRVMFLUJV-UHFFFAOYSA-N 6-ethylpyridine-2-carboxylic acid Chemical compound CCC1=CC=CC(C(O)=O)=N1 PKCFVDRVMFLUJV-UHFFFAOYSA-N 0.000 description 1
- RJPPMBCAQUDRHD-UHFFFAOYSA-N 6-ethylpyridine-2-carboxylic acid;hydrochloride Chemical compound Cl.CCC1=CC=CC(C(O)=O)=N1 RJPPMBCAQUDRHD-UHFFFAOYSA-N 0.000 description 1
- QAXHTSNJICYTNJ-UHFFFAOYSA-N 7-(3-chloropropoxy)-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(OCCCCl)C=C3N=CC=2)=N1 QAXHTSNJICYTNJ-UHFFFAOYSA-N 0.000 description 1
- KADXQVPLDAIPCU-UHFFFAOYSA-N 7-(3-chloropropoxy)-6-methoxy-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1=CN=C2C=C(OCCCCl)C(OC)=CC2=C1C1=C2CCCN2N=C1C1=CC=CC=N1 KADXQVPLDAIPCU-UHFFFAOYSA-N 0.000 description 1
- SVVFMRRRUDCTEU-UHFFFAOYSA-N 7-(3-imidazol-1-ylpropoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1=CN=CN1CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC=N1 SVVFMRRRUDCTEU-UHFFFAOYSA-N 0.000 description 1
- HCGPPESLAMDDAV-UHFFFAOYSA-N 7-(5-chloropentoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C=1C=NC2=CC(OCCCCCCl)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 HCGPPESLAMDDAV-UHFFFAOYSA-N 0.000 description 1
- YMQUQHMTAPJFGE-UHFFFAOYSA-N 7-[(1-methylpiperidin-2-yl)methoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline;hydrochloride Chemical compound Cl.CN1CCCCC1COC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 YMQUQHMTAPJFGE-UHFFFAOYSA-N 0.000 description 1
- NTLIVABFYSTQKT-UHFFFAOYSA-N 7-[(1-methylpiperidin-4-yl)methoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1CN(C)CCC1COC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 NTLIVABFYSTQKT-UHFFFAOYSA-N 0.000 description 1
- RMPSTGPGEPDIIH-UHFFFAOYSA-N 7-[3-(1-methylimidazol-2-yl)sulfonylpropoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound CN1C=CN=C1S(=O)(=O)CCCOC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 RMPSTGPGEPDIIH-UHFFFAOYSA-N 0.000 description 1
- UNMSCVJYABOLCF-UHFFFAOYSA-N 7-[3-(4-chlorophenyl)sulfanylpropoxy]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline Chemical compound C1=CC(Cl)=CC=C1SCCCOC1=CC=C(C(=CC=N2)C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)C2=C1 UNMSCVJYABOLCF-UHFFFAOYSA-N 0.000 description 1
- LEUSTBDQUPETSC-UHFFFAOYSA-N 7-benzyl-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(CC=4C=CC=CC=4)C=C3N=CC=2)=N1 LEUSTBDQUPETSC-UHFFFAOYSA-N 0.000 description 1
- AGMXSOARXXPPIJ-UHFFFAOYSA-N 7-bromo-4-methylquinoline Chemical compound BrC1=CC=C2C(C)=CC=NC2=C1 AGMXSOARXXPPIJ-UHFFFAOYSA-N 0.000 description 1
- PFLYUEAPFSFREG-QFIPXVFZSA-N 7-chloro-4-[(6s)-2-(6-methylpyridin-2-yl)-6-(phenylmethoxymethyl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CC[C@@H](COCC=4C=CC=CC=4)N3N=2)C=2C3=CC=C(Cl)C=C3N=CC=2)=N1 PFLYUEAPFSFREG-QFIPXVFZSA-N 0.000 description 1
- LHVDBGUWEDSDKH-UHFFFAOYSA-N 7-ethenyl-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=CC=C(C=C)C=C3N=CC=2)=N1 LHVDBGUWEDSDKH-UHFFFAOYSA-N 0.000 description 1
- HMAQVWHFUQINJV-UHFFFAOYSA-N 7-ethoxy-4-[3-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-4-yl]quinoline Chemical compound C=1C=NC2=CC(OCC)=CC=C2C=1C(C=12)CCN2N=CC=1C1=CC=CC(C)=N1 HMAQVWHFUQINJV-UHFFFAOYSA-N 0.000 description 1
- VKCKCXSNMMBEQJ-UHFFFAOYSA-N 7-ethoxy-4-methylquinoline Chemical compound CC1=CC=NC2=CC(OCC)=CC=C21 VKCKCXSNMMBEQJ-UHFFFAOYSA-N 0.000 description 1
- ITOHSZXAKKBTMJ-UHFFFAOYSA-N 7-fluoro-4-methylquinoline Chemical compound FC1=CC=C2C(C)=CC=NC2=C1 ITOHSZXAKKBTMJ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- MWNTTWAKXXEUET-UHFFFAOYSA-N 8-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=C3CCCN3N=2)C=2C3=NC=CC=C3C=CC=2)=N1 MWNTTWAKXXEUET-UHFFFAOYSA-N 0.000 description 1
- VDYUHSAOAJZHOM-UHFFFAOYSA-N 8-ethoxy-4-methylquinoline Chemical compound C1=CN=C2C(OCC)=CC=CC2=C1C VDYUHSAOAJZHOM-UHFFFAOYSA-N 0.000 description 1
- VIEPPTLGGQIVDC-UHFFFAOYSA-N 8-fluoro-4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1F VIEPPTLGGQIVDC-UHFFFAOYSA-N 0.000 description 1
- CGLOSACZKHEASF-UHFFFAOYSA-N 8-methoxy-4-methylquinoline Chemical compound C1=CN=C2C(OC)=CC=CC2=C1C CGLOSACZKHEASF-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- FNFTYYKPWLFASR-MRXNPFEDSA-N BrC1=CC=C(C([C@@H](CCN2N=C3)C2=C3C2=NC=CC=C2)=CC=N2)C2=C1 Chemical compound BrC1=CC=C(C([C@@H](CCN2N=C3)C2=C3C2=NC=CC=C2)=CC=N2)C2=C1 FNFTYYKPWLFASR-MRXNPFEDSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BYEFZPBRUMWOQV-UHFFFAOYSA-N C1=CC(=CC2=C1C=CC(=N2)C3=CC=NN3)C(=O)O Chemical compound C1=CC(=CC2=C1C=CC(=N2)C3=CC=NN3)C(=O)O BYEFZPBRUMWOQV-UHFFFAOYSA-N 0.000 description 1
- HIMPCIUBDQDJTJ-UHFFFAOYSA-N C1=CC=C2C(=C1)C(=CC=N2)C3=C(NC=C3C4=CC=CC=N4)CCCC(=O)O Chemical compound C1=CC=C2C(=C1)C(=CC=N2)C3=C(NC=C3C4=CC=CC=N4)CCCC(=O)O HIMPCIUBDQDJTJ-UHFFFAOYSA-N 0.000 description 1
- WOUSCYUQHKRQSZ-UHFFFAOYSA-N C1=CC=C2C(CC(=O)C)=CC=C(F)C2=C1 Chemical compound C1=CC=C2C(CC(=O)C)=CC=C(F)C2=C1 WOUSCYUQHKRQSZ-UHFFFAOYSA-N 0.000 description 1
- BQMNHJBTSKSMQK-UHFFFAOYSA-N CC1=CC=CC(C2=NN(CCC3C(C=C4)=CC=C4Cl)C3=C2C(C=C2)=CC=C2F)=N1 Chemical compound CC1=CC=CC(C2=NN(CCC3C(C=C4)=CC=C4Cl)C3=C2C(C=C2)=CC=C2F)=N1 BQMNHJBTSKSMQK-UHFFFAOYSA-N 0.000 description 1
- JVDABALSKKOSTA-UHFFFAOYSA-N CCOC(=O)C1=C2CCCN2N=C1C3C=CC=CN3C Chemical compound CCOC(=O)C1=C2CCCN2N=C1C3C=CC=CN3C JVDABALSKKOSTA-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 108010036395 Endoglin Proteins 0.000 description 1
- PTVSRINJXWDIKP-UHFFFAOYSA-N Ethyl 4-pentenoate Chemical compound CCOC(=O)CCC=C PTVSRINJXWDIKP-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- 238000007341 Heck reaction Methods 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 102000006835 Lamins Human genes 0.000 description 1
- 108010047294 Lamins Proteins 0.000 description 1
- YDQJXVYGARVLRT-UHFFFAOYSA-N Lepidine Natural products C=1C=CC(CC=2NC=CN=2)=CC=1OC=1C(OC)=CC=CC=1CC1=NC=CN1 YDQJXVYGARVLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- 150000004008 N-nitroso compounds Chemical class 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 238000010934 O-alkylation reaction Methods 0.000 description 1
- CQGRLHBOVUGVEA-UHFFFAOYSA-N OOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOO CQGRLHBOVUGVEA-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- PWATWSYOIIXYMA-UHFFFAOYSA-N Pentylbenzene Chemical compound CCCCCC1=CC=CC=C1 PWATWSYOIIXYMA-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 108010007945 Smad Proteins Proteins 0.000 description 1
- 102000007374 Smad Proteins Human genes 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 1
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 description 1
- FSNYMFAJCXNESU-OAHLLOKOSA-N [(6r)-3-(4-fluorophenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-6-yl]methanol Chemical compound CC1=CC=CC(C=2C(=C3CC[C@H](CO)N3N=2)C=2C=CC(F)=CC=2)=N1 FSNYMFAJCXNESU-OAHLLOKOSA-N 0.000 description 1
- UVDMHKDOGHWODV-UHFFFAOYSA-N [1-(1,8-naphthyridin-2-yl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound C1=CC=NC2=NC(C(CC=3C4=CC=CC=C4N=CC=3)=NN)=CC=C21 UVDMHKDOGHWODV-UHFFFAOYSA-N 0.000 description 1
- LFRTZRLAKFDIPT-UHFFFAOYSA-N [1-(3-chlorophenyl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC(Cl)=C1 LFRTZRLAKFDIPT-UHFFFAOYSA-N 0.000 description 1
- UZZLTVPCIQKBBL-UHFFFAOYSA-N [1-(3-fluorophenyl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC(F)=C1 UZZLTVPCIQKBBL-UHFFFAOYSA-N 0.000 description 1
- WSVWCGRMBCNNEK-UHFFFAOYSA-N [1-(4-chlorophenyl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=C(Cl)C=C1 WSVWCGRMBCNNEK-UHFFFAOYSA-N 0.000 description 1
- OKVGXNGNWYOVMI-UHFFFAOYSA-N [1-(4-chloropyridin-2-yl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC(Cl)=CC=N1 OKVGXNGNWYOVMI-UHFFFAOYSA-N 0.000 description 1
- FHVVGRWHLMQKGI-UHFFFAOYSA-N [1-(6-methylpyridin-2-yl)-2-quinolin-4-ylethylidene]hydrazine Chemical compound CC1=CC=CC(C(CC=2C3=CC=CC=C3N=CC=2)=NN)=N1 FHVVGRWHLMQKGI-UHFFFAOYSA-N 0.000 description 1
- OOUBPPJTRPIJDJ-UHFFFAOYSA-N [1-[3-fluoro-5-(trifluoromethyl)phenyl]-2-quinolin-4-ylethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC(F)=CC(C(F)(F)F)=C1 OOUBPPJTRPIJDJ-UHFFFAOYSA-N 0.000 description 1
- FNPGMBUGGBDFQD-UHFFFAOYSA-N [2-(1,10-phenanthrolin-4-yl)-1-pyridin-2-ylethylidene]hydrazine Chemical compound C=1C=NC(C2=NC=CC=C2C=C2)=C2C=1CC(=NN)C1=CC=CC=N1 FNPGMBUGGBDFQD-UHFFFAOYSA-N 0.000 description 1
- HMKNDYWZEMZSHJ-UHFFFAOYSA-N [2-(6,8-dimethoxyquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethylidene]hydrazine Chemical compound C12=CC(OC)=CC(OC)=C2N=CC=C1CC(=NN)C1=CC=CC(C)=N1 HMKNDYWZEMZSHJ-UHFFFAOYSA-N 0.000 description 1
- GJHKZJOXWQVNJR-UHFFFAOYSA-N [2-(6,8-dimethoxyquinolin-4-yl)-1-pyridin-2-ylethylidene]hydrazine Chemical compound C12=CC(OC)=CC(OC)=C2N=CC=C1CC(=NN)C1=CC=CC=N1 GJHKZJOXWQVNJR-UHFFFAOYSA-N 0.000 description 1
- AIGGPPGTBRFMAK-UHFFFAOYSA-N [2-quinolin-4-yl-1-[3-(trifluoromethoxy)phenyl]ethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC(OC(F)(F)F)=C1 AIGGPPGTBRFMAK-UHFFFAOYSA-N 0.000 description 1
- NUEXMYWEOFOUTI-UHFFFAOYSA-N [2-quinolin-4-yl-1-[3-(trifluoromethyl)phenyl]ethylidene]hydrazine Chemical compound C=1C=NC2=CC=CC=C2C=1CC(=NN)C1=CC=CC(C(F)(F)F)=C1 NUEXMYWEOFOUTI-UHFFFAOYSA-N 0.000 description 1
- CUPCXDRVHZGUGE-UHFFFAOYSA-N [4-[3-(benzylamino)phenyl]-8-(trifluoromethyl)quinolin-3-yl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1=CN=C2C(C(F)(F)F)=CC=CC2=C1C(C=1)=CC=CC=1NCC1=CC=CC=C1 CUPCXDRVHZGUGE-UHFFFAOYSA-N 0.000 description 1
- 150000007960 acetonitrile Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 229930008407 benzylideneacetone Natural products 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- VIHAEDVKXSOUAT-UHFFFAOYSA-N but-2-en-4-olide Chemical compound O=C1OCC=C1 VIHAEDVKXSOUAT-UHFFFAOYSA-N 0.000 description 1
- 125000005467 butylenyl group Chemical group 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- ZMCUDHNSHCRDBT-UHFFFAOYSA-M caesium bicarbonate Chemical compound [Cs+].OC([O-])=O ZMCUDHNSHCRDBT-UHFFFAOYSA-M 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000006315 carbonylation Effects 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000034196 cell chemotaxis Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 125000000259 cinnolinyl group Chemical class N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- LWJYMKDMGMOTSB-UHFFFAOYSA-L dichlorotin;hydrate Chemical compound O.Cl[Sn]Cl LWJYMKDMGMOTSB-UHFFFAOYSA-L 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- DWLVWMUCHSLGSU-UHFFFAOYSA-N dimethylcarbamic acid Chemical compound CN(C)C(O)=O DWLVWMUCHSLGSU-UHFFFAOYSA-N 0.000 description 1
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
- LNGNZSMIUVQZOX-UHFFFAOYSA-L disodium;dioxido(sulfanylidene)-$l^{4}-sulfane Chemical compound [Na+].[Na+].[O-]S([O-])=S LNGNZSMIUVQZOX-UHFFFAOYSA-L 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- GLAJARQUMCDEQQ-UHFFFAOYSA-N ethyl 2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-3-carboxylate Chemical compound CCOC(=O)C1=C2CCCN2N=C1C1=CC=CC(C)=N1 GLAJARQUMCDEQQ-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- VBIGMJICRVVEKJ-UHFFFAOYSA-N ethyl 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-2-carboxylate Chemical compound C=12C=CC=CC2=NC(C(=O)OCC)=CC=1C1=C2CCCN2N=C1C1=CC=CC=N1 VBIGMJICRVVEKJ-UHFFFAOYSA-N 0.000 description 1
- OYESLKRPUBUBSW-UHFFFAOYSA-N ethyl 4-(5-oxooxolan-3-yl)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1CC(=O)OC1 OYESLKRPUBUBSW-UHFFFAOYSA-N 0.000 description 1
- VSSBEFLNRJBGFH-UHFFFAOYSA-N ethyl 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-7-carboxylate Chemical compound C=1C=NC2=CC(C(=O)OCC)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 VSSBEFLNRJBGFH-UHFFFAOYSA-N 0.000 description 1
- YFDSZKJAZGSEOD-UHFFFAOYSA-N ethyl 4-bromoquinoline-2-carboxylate Chemical compound C1=CC=CC2=NC(C(=O)OCC)=CC(Br)=C21 YFDSZKJAZGSEOD-UHFFFAOYSA-N 0.000 description 1
- LEPOSXBRLZEUTJ-UHFFFAOYSA-N ethyl 5-[tert-butyl(dimethyl)silyl]oxy-4-hydroxypentanoate Chemical compound CCOC(=O)CCC(O)CO[Si](C)(C)C(C)(C)C LEPOSXBRLZEUTJ-UHFFFAOYSA-N 0.000 description 1
- AHMGOYHQXHQSQE-UHFFFAOYSA-N ethyl 5-fluoropyridine-2-carboxylate Chemical compound CCOC(=O)C1=CC=C(F)C=N1 AHMGOYHQXHQSQE-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- PWOYTBYNBYNZCO-UHFFFAOYSA-N ethyl quinoline-2-carboxylate Chemical compound C1=CC=CC2=NC(C(=O)OCC)=CC=C21 PWOYTBYNBYNZCO-UHFFFAOYSA-N 0.000 description 1
- 125000005469 ethylenyl group Chemical group 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000005027 hydroxyaryl group Chemical group 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005468 isobutylenyl group Chemical group 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000005053 lamin Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- OUTILEHLSPAZIN-UHFFFAOYSA-M magnesium;ethylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]CC1=CC=CC=C1 OUTILEHLSPAZIN-UHFFFAOYSA-M 0.000 description 1
- SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- WDWDWGRYHDPSDS-UHFFFAOYSA-N methanimine Chemical compound N=C WDWDWGRYHDPSDS-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- PAUWJGNLAVWRMD-UHFFFAOYSA-N methyl 1,8-naphthyridine-2-carboxylate Chemical compound C1=CC=NC2=NC(C(=O)OC)=CC=C21 PAUWJGNLAVWRMD-UHFFFAOYSA-N 0.000 description 1
- XOUMAABXMXACFQ-UHFFFAOYSA-N methyl 2-fluoro-3-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(F)(F)F)=C1F XOUMAABXMXACFQ-UHFFFAOYSA-N 0.000 description 1
- QAFJIJWLEBLXHH-UHFFFAOYSA-N methyl 2-fluorobenzoate Chemical compound COC(=O)C1=CC=CC=C1F QAFJIJWLEBLXHH-UHFFFAOYSA-N 0.000 description 1
- YXZNVLYXBIIIOB-UHFFFAOYSA-N methyl 3-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(F)=C1 YXZNVLYXBIIIOB-UHFFFAOYSA-N 0.000 description 1
- QNCMNBKPTMWICH-UHFFFAOYSA-N methyl 4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxylate Chemical compound C12=CC(C(=O)OC)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC=N1 QNCMNBKPTMWICH-UHFFFAOYSA-N 0.000 description 1
- PYUBAZVUCQOMKF-UHFFFAOYSA-N methyl 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxylate Chemical compound C12=CC(C(=O)OC)=CC=C2N=CC=C1C1=C2CCCN2N=C1C1=CC=CC(C)=N1 PYUBAZVUCQOMKF-UHFFFAOYSA-N 0.000 description 1
- UNKSUKIJRHGQPM-UHFFFAOYSA-N methyl 4-acetyloxy-3-phenylbut-2-enoate Chemical compound COC(=O)C=C(COC(C)=O)C1=CC=CC=C1 UNKSUKIJRHGQPM-UHFFFAOYSA-N 0.000 description 1
- VTENWIPSWAMPKI-UHFFFAOYSA-N methyl 4-chloropyridine-2-carboxylate Chemical compound COC(=O)C1=CC(Cl)=CC=N1 VTENWIPSWAMPKI-UHFFFAOYSA-N 0.000 description 1
- GGOYGQPFRKAZTI-UHFFFAOYSA-N methyl 4-ethylpyridine-2-carboxylate Chemical compound CCC1=CC=NC(C(=O)OC)=C1 GGOYGQPFRKAZTI-UHFFFAOYSA-N 0.000 description 1
- MSEBQGULDWDIRW-UHFFFAOYSA-N methyl 4-fluorobenzoate Chemical compound COC(=O)C1=CC=C(F)C=C1 MSEBQGULDWDIRW-UHFFFAOYSA-N 0.000 description 1
- TWUXBVMXSBEKHA-UHFFFAOYSA-N methyl 6-chloropyridine-2-carboxylate Chemical compound COC(=O)C1=CC=CC(Cl)=N1 TWUXBVMXSBEKHA-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- CILJSZLWPHTUIP-UHFFFAOYSA-N methyl quinoline-2-carboxylate Chemical compound C1=CC=CC2=NC(C(=O)OC)=CC=C21 CILJSZLWPHTUIP-UHFFFAOYSA-N 0.000 description 1
- XSRWQTDEIOHXSL-UHFFFAOYSA-N methyl quinoline-6-carboxylate Chemical compound N1=CC=CC2=CC(C(=O)OC)=CC=C21 XSRWQTDEIOHXSL-UHFFFAOYSA-N 0.000 description 1
- ZTZCGCCFJZVRTO-UHFFFAOYSA-N methyl quinoline-7-carboxylate Chemical compound C1=CC=NC2=CC(C(=O)OC)=CC=C21 ZTZCGCCFJZVRTO-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- OBELYHBFPVPHDG-UHFFFAOYSA-N n-(benzhydrylideneamino)-3-(4-chlorophenyl)-4-hydroxybutanamide Chemical compound C=1C=C(Cl)C=CC=1C(CO)CC(=O)NN=C(C=1C=CC=CC=1)C1=CC=CC=C1 OBELYHBFPVPHDG-UHFFFAOYSA-N 0.000 description 1
- ZCRRXCINWSMTNC-UHFFFAOYSA-N n-(benzhydrylideneamino)-3-(4-fluorophenyl)-4-hydroxybutanamide Chemical compound C=1C=C(F)C=CC=1C(CO)CC(=O)NN=C(C=1C=CC=CC=1)C1=CC=CC=C1 ZCRRXCINWSMTNC-UHFFFAOYSA-N 0.000 description 1
- DRNMHXURRYWTGP-UHFFFAOYSA-N n-(benzhydrylideneamino)-4-hydroxy-3,3-dimethylbutanamide Chemical compound C=1C=CC=CC=1C(=NNC(=O)CC(C)(CO)C)C1=CC=CC=C1 DRNMHXURRYWTGP-UHFFFAOYSA-N 0.000 description 1
- VFWIDQBWILDROI-UHFFFAOYSA-N n-(benzhydrylideneamino)-4-hydroxy-3-(3-methoxyphenyl)butanamide Chemical compound COC1=CC=CC(C(CO)CC(=O)NN=C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 VFWIDQBWILDROI-UHFFFAOYSA-N 0.000 description 1
- RFTMIAAQVNHPBE-UHFFFAOYSA-N n-(benzhydrylideneamino)-5-[tert-butyl(dimethyl)silyl]oxy-4-hydroxypentanamide Chemical compound C=1C=CC=CC=1C(=NNC(=O)CCC(O)CO[Si](C)(C)C(C)(C)C)C1=CC=CC=C1 RFTMIAAQVNHPBE-UHFFFAOYSA-N 0.000 description 1
- HTSKAIKVBLFMFK-UHFFFAOYSA-N n-(cyclopropylmethyl)-3-[4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl]quinolin-7-yl]oxy-n-propylpropan-1-amine Chemical compound C1CC1CN(CCC)CCCOC(C=C1N=CC=2)=CC=C1C=2C1=C2CCCN2N=C1C1=CC=CC(C)=N1 HTSKAIKVBLFMFK-UHFFFAOYSA-N 0.000 description 1
- IZYPQTHXWJFICZ-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxamide Chemical compound C=1C=NC2=CC(C(=O)NCCCN(C)C)=CC=C2C=1C1=C2CCCN2N=C1C1=CC=CC=N1 IZYPQTHXWJFICZ-UHFFFAOYSA-N 0.000 description 1
- WOZJVBYSVVBLNZ-UHFFFAOYSA-N n-cyclopentyl-4-(2-pyridin-2-yl-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-7-carboxamide Chemical compound C=1C=C2C(C=3C(=NN4CCCC4=3)C=3N=CC=CC=3)=CC=NC2=CC=1C(=O)NC1CCCC1 WOZJVBYSVVBLNZ-UHFFFAOYSA-N 0.000 description 1
- BEENTKNKPLFNKS-UHFFFAOYSA-N n-ethyl-n'-(3-pyrrolidin-1-ylpropyl)methanediimine Chemical compound CCN=C=NCCCN1CCCC1 BEENTKNKPLFNKS-UHFFFAOYSA-N 0.000 description 1
- 238000005648 named reaction Methods 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 150000002912 oxalic acid derivatives Chemical class 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NNOQIGNUIUKVDJ-UHFFFAOYSA-N oxolan-2-ylmethyl methanesulfonate Chemical compound CS(=O)(=O)OCC1CCCO1 NNOQIGNUIUKVDJ-UHFFFAOYSA-N 0.000 description 1
- PBDBXAQKXCXZCJ-UHFFFAOYSA-L palladium(2+);2,2,2-trifluoroacetate Chemical compound [Pd+2].[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F PBDBXAQKXCXZCJ-UHFFFAOYSA-L 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- VLCMRTMCMQJSKM-UHFFFAOYSA-N phenyl-[4-phenyl-8-(trifluoromethyl)quinolin-3-yl]methanone Chemical compound C=1C=CC=CC=1C(=O)C1=CN=C2C(C(F)(F)F)=CC=CC2=C1C1=CC=CC=C1 VLCMRTMCMQJSKM-UHFFFAOYSA-N 0.000 description 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N piperidine-2,6-dione Chemical compound O=C1CCCC(=O)N1 KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 125000005470 propylenyl group Chemical group 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- CGNOCXFIMTXTGY-UHFFFAOYSA-N pyridine-2-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC(=O)C1=CC=CC=N1 CGNOCXFIMTXTGY-UHFFFAOYSA-N 0.000 description 1
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical compound SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- BWDCBBZUYJDNJZ-UHFFFAOYSA-N quinazolin-7-ol Chemical compound C1=NC=NC2=CC(O)=CC=C21 BWDCBBZUYJDNJZ-UHFFFAOYSA-N 0.000 description 1
- 125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 description 1
- SHHNAJHUBYXDQP-UHFFFAOYSA-N quinoline-7-sulfonamide Chemical compound C1=CC=NC2=CC(S(=O)(=O)N)=CC=C21 SHHNAJHUBYXDQP-UHFFFAOYSA-N 0.000 description 1
- 238000003156 radioimmunoprecipitation Methods 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- WBQTXTBONIWRGK-UHFFFAOYSA-N sodium;propan-2-olate Chemical compound [Na+].CC(C)[O-] WBQTXTBONIWRGK-UHFFFAOYSA-N 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- BWHOZHOGCMHOBV-BQYQJAHWSA-N trans-benzylideneacetone Chemical compound CC(=O)\C=C\C1=CC=CC=C1 BWHOZHOGCMHOBV-BQYQJAHWSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29346401P | 2001-05-24 | 2001-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ20033128A3 CZ20033128A3 (cs) | 2004-06-16 |
| CZ303808B6 true CZ303808B6 (cs) | 2013-05-09 |
Family
ID=23129192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20033128A CZ303808B6 (cs) | 2001-05-24 | 2002-05-13 | Nové pyrazolové deriváty jako farmaceutická cinidla |
Country Status (37)
Families Citing this family (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2289116T3 (es) * | 2001-05-24 | 2008-02-01 | Eli Lilly And Company | Nuevos derivados de pirrol como agentes farmaceuticos. |
| ES2292839T3 (es) * | 2001-12-11 | 2008-03-16 | Smithkline Beecham Corporation | Derivados de pirazolo-piridina como agentes contra el herpes. |
| EP1543001B1 (en) * | 2002-09-17 | 2007-08-15 | Eli Lilly And Company | Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer |
| CA2506799A1 (en) * | 2002-11-21 | 2004-06-10 | Eli Lilly And Company | Mixed lineage kinase modulators |
| WO2004048381A2 (en) * | 2002-11-22 | 2004-06-10 | Eli Lilly And Company | Pyrazoloazepine compounds as pharmaceutical agents |
| UA80571C2 (en) * | 2002-11-22 | 2007-10-10 | Lilly Co Eli | Quinolinyl-pyrrolopyrazoles |
| AU2003290734A1 (en) * | 2002-11-27 | 2004-06-23 | Eli Lilly And Company | Novel compounds as pharmaceutical agents |
| CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| US7511065B2 (en) * | 2003-11-12 | 2009-03-31 | Eli Lilly And Company | Mixed lineage kinase modulators |
| EP1723146A1 (en) * | 2004-03-01 | 2006-11-22 | Eli Lilly And Company | Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| TW200639163A (en) * | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
| AU2006228683B2 (en) | 2005-04-01 | 2012-02-02 | Vfp Therapies | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-Alzheimer agents |
| SI1910370T1 (sl) * | 2005-07-22 | 2015-06-30 | Eli Lilly And Company | Piridin kinolin substituirani pirolo(1,2-b)pirazol monohidrat kot tgf-beta inhibitor |
| WO2007021966A1 (en) | 2005-08-12 | 2007-02-22 | Synta Pharmaceuticals Corp. | Pyrazole compounds that modulate hsp90 activity |
| WO2007076127A2 (en) * | 2005-12-22 | 2007-07-05 | Biogen Idec Ma Inc | Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
| DE102005061840A1 (de) | 2005-12-23 | 2007-06-28 | Merck Patent Gmbh | Triazolderivate |
| US8034834B2 (en) | 2006-05-25 | 2011-10-11 | Synta Pharmaceuticals Corp. | Method for treating proliferative disorders with HSP90 inhibitors |
| DK2918288T3 (da) | 2006-10-03 | 2017-11-27 | Genzyme Corp | Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi |
| PE20090717A1 (es) * | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
| ES2398677T3 (es) * | 2007-12-12 | 2013-03-20 | E. I. Du Pont De Nemours And Company | Pirazoles bicíclicos fungicidas |
| EP2373664B1 (en) * | 2008-12-19 | 2013-06-12 | Nerviano Medical Sciences S.r.l. | Bicyclic pyrazoles as protein kinase inhibitors |
| EP2419105A4 (en) * | 2009-04-17 | 2012-09-12 | Summa Health Systems Llc | USE OF TRANSFORMATION OF GROWTH FACTOR B RECEPTOR INHIBITORS TO SUPPRESS OCULAR HEALING |
| AR081810A1 (es) * | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | Piridinilpirazoles biciclicos |
| EP2560640A1 (en) | 2010-04-19 | 2013-02-27 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor |
| EP2402339A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2402337A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2401915A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2402340A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2402338A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| US8871744B2 (en) | 2010-07-21 | 2014-10-28 | B & G Partyers, LLC | Compounds and methods for selectively targeting tumor-associated mucins |
| WO2012138945A1 (en) | 2011-04-08 | 2012-10-11 | Aestus Therapeutics, Inc. | Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta |
| WO2013014262A1 (en) | 2011-07-27 | 2013-01-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating myhre syndrome |
| BR112014009789A2 (pt) | 2011-10-26 | 2017-04-25 | Seattle Children's Res Inst | cisteamina no tratamento da doença fibrótica |
| CA2853799A1 (en) | 2011-11-02 | 2013-05-10 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors |
| AU2012332424A1 (en) | 2011-11-02 | 2014-06-05 | Synta Pharmaceuticals Corp. | Combination therapy of Hsp90 inhibitors with platinum-containing agents |
| WO2013074594A1 (en) | 2011-11-14 | 2013-05-23 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitors with braf inhibitors |
| US9782452B2 (en) | 2011-11-22 | 2017-10-10 | Cornell University | Methods for stimulating hematopoietic recovery by inhibiting TGFβ signaling |
| ES2966030T3 (es) | 2012-10-05 | 2024-04-18 | Kadmon Corp Llc | Anticuerpos anti-VEGFR-2/KDR humanos |
| TWI443096B (zh) | 2012-12-18 | 2014-07-01 | Ind Tech Res Inst | 3-(5-(4-(3-氟丙基)哌嗪-1-基)苯並咪唑-2-基)-1-氮雜薁-2-酮之單水合晶型及其製備方法與藥學組成物 |
| JP2016507537A (ja) * | 2013-02-07 | 2016-03-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 置換アセチレン誘導体およびmGluR4の正のアロステリックモジュレーターとしてのそれらの使用 |
| CA3184040A1 (en) | 2013-03-14 | 2014-10-02 | The Brigham And Women's Hospital, Inc. | Compositions and methods for epithelial stem cell expansion comprising a wnt agonist and a histone deacetylase inhibitor |
| US8975417B2 (en) * | 2013-05-27 | 2015-03-10 | Novartis Ag | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |
| KR102408261B1 (ko) | 2014-02-03 | 2022-06-10 | 비타이 파마슈티컬즈, 엘엘씨 | Ror-감마의 디하이드로피롤로피리딘 저해제 |
| WO2016037016A1 (en) | 2014-09-03 | 2016-03-10 | The Brigham And Women's Hospital, Inc. | Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss |
| JO3336B1 (ar) | 2014-10-07 | 2019-03-13 | Lilly Co Eli | مركبات أمينو بيريديلوكسي بيرازول |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| EP3277673B1 (en) | 2015-04-01 | 2022-05-04 | Rigel Pharmaceuticals, Inc. | Tgf-beta inhibitors |
| EP3313420B1 (en) | 2015-06-25 | 2024-03-13 | The Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| US10301261B2 (en) | 2015-08-05 | 2019-05-28 | Vitae Pharmaceuticals, Llc | Substituted indoles as modulators of ROR-gamma |
| EP3868750A1 (en) | 2015-11-20 | 2021-08-25 | Vitae Pharmaceuticals, LLC | Modulators of ror-gamma |
| AU2017205194A1 (en) | 2016-01-08 | 2018-07-19 | Massachusetts Institute Of Technology | Production of differentiated enteroendocrine cells and insulin producing cells |
| TWI757266B (zh) | 2016-01-29 | 2022-03-11 | 美商維它藥物有限責任公司 | ROR-γ調節劑 |
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
| DK3429603T3 (da) | 2016-03-15 | 2022-03-14 | Childrens Medical Center | Fremgangsmåder og sammensætninger vedrørende ekspansion af hæmatopoietiske stamceller |
| RU2737737C2 (ru) * | 2016-06-13 | 2020-12-02 | Джинфлит Терапьютикс (Шанхай) Инк. | АЛЬФА- И БЕТА-НЕНАСЫЩЕННОЕ АМИДНОЕ СОЕДИНЕНИЕ - ПРОИЗВОДНОЕ БЕНЗОТРИАЗОЛА, ПРИМЕНЯЕМОЕ В КАЧЕСТВЕ ИНГИБИТОРА TGF-βRI |
| KR102365333B1 (ko) | 2016-07-29 | 2022-02-23 | 상하이 잉리 파마슈티컬 컴퍼니 리미티드 | 질소 함유 방향족 헤테로 고리 화합물, 이의 제조 방법, 약물 조성물 및 응용 |
| CN110392686A (zh) | 2016-12-30 | 2019-10-29 | 频率治疗公司 | 1h-吡咯-2,5-二酮化合物以及使用它们来诱导干/祖支持细胞自我更新的方法 |
| PL3618829T3 (pl) * | 2017-05-05 | 2023-11-20 | Arcus Biosciences, Inc. | Pochodne chinazolinopirydyny do leczenia zaburzeń związanych z nowotworem |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
| CN111225914B (zh) | 2017-07-24 | 2022-10-11 | 生命医药有限责任公司 | RORγ的抑制剂 |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| PT3691620T (pt) | 2017-10-05 | 2022-10-06 | Fulcrum Therapeutics Inc | Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd |
| AU2018348930A1 (en) | 2017-10-11 | 2020-03-26 | F. Hoffmann-La Roche Ag | Bicyclic compounds for use as RIP 1 kinase inhibitors |
| JP2021035911A (ja) * | 2017-11-15 | 2021-03-04 | 大日本住友製薬株式会社 | 縮環ピラゾール誘導体及びその医薬用途 |
| CN111479809B (zh) | 2017-12-13 | 2021-10-29 | 劲方医药科技(上海)有限公司 | 一种TGF-βRI抑制剂的晶型、盐型及其制备方法 |
| CN110066276B (zh) | 2018-01-24 | 2020-09-18 | 上海璎黎药业有限公司 | 芳香杂环化合物、其中间体、制备方法、药物组合物和应用 |
| CN110066277B (zh) | 2018-01-24 | 2021-07-23 | 上海璎黎药业有限公司 | 芳香杂环取代烯烃化合物、其制备方法、药物组合物和应用 |
| WO2019183245A1 (en) | 2018-03-20 | 2019-09-26 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| US20210254006A1 (en) | 2018-06-06 | 2021-08-19 | Ideaya Biosciences, Inc. | Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds |
| CN112867724B (zh) * | 2018-07-23 | 2024-06-04 | 熙源安健医药(北京)有限公司 | 二膦酸盐药物缀合物 |
| WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
| US11162071B2 (en) | 2018-08-17 | 2021-11-02 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating JAG-1 |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| WO2020088526A1 (zh) * | 2018-10-31 | 2020-05-07 | 南京明德新药研发有限公司 | 作为TGF-βR1激酶抑制剂的双环吡唑类化合物 |
| CN113347965B (zh) * | 2018-11-22 | 2025-02-18 | 生物医学研究机构基金会 | TGFβ抑制剂和前药 |
| AU2019417418B2 (en) | 2018-12-27 | 2025-02-27 | Nexys Therapeutics, Inc. | (pyridin-2-yl)amine derivatives as ΤGFβR1 (Alk5) inhibitors for the treatment of cancer |
| AU2019419414A1 (en) | 2018-12-31 | 2023-04-06 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| JP7331116B2 (ja) * | 2019-01-24 | 2023-08-22 | チアンスー アオサイカン ファーマシューティカル カンパニー,リミティド | TGF-βR1キナーゼ阻害剤としての5-(4-ピリジルオキシ)ピラゾール類化合物 |
| WO2020160151A1 (en) * | 2019-01-31 | 2020-08-06 | Kyorin Pharmaceutical Co., Ltd. | 15-pgdh inhibitors |
| US20220177978A1 (en) | 2019-04-02 | 2022-06-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
| CN113557236B (zh) * | 2019-06-10 | 2022-05-10 | 中国科学院广州生物医药与健康研究院 | 一种双功能免疫调节剂及其在药学上可接受的盐、药物组合物 |
| WO2021142086A1 (en) | 2020-01-08 | 2021-07-15 | Synthis Therapeutics, Inc. | Alk5 inhibitor conjugates and uses thereof |
| CN114867723B (zh) * | 2020-07-23 | 2023-05-30 | 江苏奥赛康药业有限公司 | 作为TGF-βR1抑制剂的吡啶氧基连吡唑类化合物的盐型、晶型以及其药物组合物 |
| CN116249692B (zh) | 2020-09-28 | 2024-08-23 | 四川科伦博泰生物医药股份有限公司 | 吡唑类化合物及其制备方法和用途 |
| CN114437082B (zh) * | 2020-11-06 | 2025-04-04 | 江苏先声药业有限公司 | 喹啉类化合物 |
| CN115703750B (zh) * | 2021-08-17 | 2024-07-02 | 黑龙江华瑞生物科技有限公司 | 一种1-氨基-4-甲基哌嗪的提取纯化方法 |
| CN114249742B (zh) * | 2021-11-22 | 2022-11-01 | 郑州大学 | 一种光气探针、荧光书写检测笔及其在光气检测中的应用 |
| CN115969801B (zh) * | 2023-03-21 | 2023-08-25 | 劲方医药科技(上海)有限公司 | 用于癌症的药物组合物及其制备方法 |
| WO2024258967A1 (en) | 2023-06-13 | 2024-12-19 | Synthis Therapeutics, Inc. | Anti-cd5 antibodies and their uses |
| GB202309553D0 (en) | 2023-06-24 | 2023-08-09 | Ucl Business Ltd | Compostions and uses thereof |
| CN118652155A (zh) * | 2024-06-17 | 2024-09-17 | 南京工业大学 | 一种二芳基乙炔的合成方法 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0531901A2 (en) * | 1991-09-09 | 1993-03-17 | Fujisawa Pharmaceutical Co., Ltd. | Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity |
| US5358947A (en) * | 1993-09-13 | 1994-10-25 | American Cyanamid Company | Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones |
| EP0666079A1 (en) * | 1993-07-27 | 1995-08-09 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for parkinson's disease |
| US5597816A (en) * | 1992-06-17 | 1997-01-28 | The Upjohn Company | Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| US5670503A (en) * | 1993-02-26 | 1997-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| WO1997035551A1 (fr) * | 1996-03-22 | 1997-10-02 | L'oreal | Compositions de teinture des fibres keratiniques contenant des pyrazolo-azoles; leur utilisation pour la teinture comme coupleurs, procede de teinture |
| EP0923929A1 (fr) * | 1997-12-16 | 1999-06-23 | L'oreal | Compositions de teinture des fibres kératiniques centenant des pyrazolo-azoles; leur utilisation pour la teinture comme base d'oxydation, procédé de teinture; nouveaux pyrazolo-azoles |
| WO2000044743A1 (en) * | 1999-01-28 | 2000-08-03 | Nippon Shinyaku Co., Ltd. | Amide derivatives and drug compositions |
| WO2001016138A1 (en) * | 1999-08-27 | 2001-03-08 | Abbott Laboratories | Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN419395A0 (en) * | 1995-07-17 | 1995-08-10 | Treescope Development Co. Pty. Ltd. | Plant protector |
| TR200000235T2 (tr) | 1997-05-22 | 2000-05-22 | G.D. Searle &Co. | p38 kinaz inhibitörleri olarak ikame edilmiş pirazoller. |
| GB9809869D0 (en) | 1998-05-09 | 1998-07-08 | Medical Res Council | Inhibition of protein kinases |
| DE60001229T2 (de) | 1999-04-09 | 2003-10-30 | Smithkline Beecham Corp., Philadelphia | Triarylimidazole |
| GB0007405D0 (en) | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| CA2425288A1 (en) * | 2000-10-11 | 2002-05-02 | Sander G. Mills | Pyrrolidine modulators of ccr5 chemokine receptor activity |
| DE60203263T2 (de) | 2001-02-02 | 2006-02-09 | Smithkline Beecham Corp. | Pyrazolderivate gegen tgf überexprimierung |
| ES2289116T3 (es) * | 2001-05-24 | 2008-02-01 | Eli Lilly And Company | Nuevos derivados de pirrol como agentes farmaceuticos. |
| PL1633912T3 (pl) * | 2003-05-28 | 2014-11-28 | Oerlikon Textile Gmbh & Co Kg | Sposób oraz urządzenie do układania włókien wykorzystujące technikę igłowania powietrzem |
| JP4882198B2 (ja) | 2003-09-25 | 2012-02-22 | 日産自動車株式会社 | 燃料電池システム |
-
2002
- 2002-05-13 ES ES02744115T patent/ES2289116T3/es not_active Expired - Lifetime
- 2002-05-13 DE DE60221392T patent/DE60221392T2/de not_active Expired - Lifetime
- 2002-05-13 AT AT02744115T patent/ATE368041T1/de active
- 2002-05-13 CN CNA2006100946748A patent/CN1951939A/zh active Pending
- 2002-05-13 CZ CZ20033128A patent/CZ303808B6/cs not_active IP Right Cessation
- 2002-05-13 KR KR1020037015226A patent/KR100861630B1/ko not_active Expired - Fee Related
- 2002-05-13 PL PL367199A patent/PL221339B1/pl unknown
- 2002-05-13 JP JP2002591506A patent/JP4519407B2/ja not_active Expired - Fee Related
- 2002-05-13 EA EA200301289A patent/EA007782B1/ru not_active IP Right Cessation
- 2002-05-13 DK DK02744115T patent/DK1397364T3/da active
- 2002-05-13 UA UA20031110606A patent/UA76461C2/uk unknown
- 2002-05-13 CA CA2446820A patent/CA2446820C/en not_active Expired - Fee Related
- 2002-05-13 NZ NZ528525A patent/NZ528525A/en not_active IP Right Cessation
- 2002-05-13 SI SI200230626T patent/SI1397364T1/sl unknown
- 2002-05-13 IL IL15851202A patent/IL158512A0/xx unknown
- 2002-05-13 EP EP02744115A patent/EP1397364B1/en not_active Expired - Lifetime
- 2002-05-13 SK SK1416-2003A patent/SK287857B6/sk not_active IP Right Cessation
- 2002-05-13 US US10/477,111 patent/US7087626B2/en not_active Expired - Fee Related
- 2002-05-13 PT PT02744115T patent/PT1397364E/pt unknown
- 2002-05-13 HR HR20030961A patent/HRP20030961B1/xx not_active IP Right Cessation
- 2002-05-13 MX MXPA03010630A patent/MXPA03010630A/es active IP Right Grant
- 2002-05-13 CN CNB028105087A patent/CN1269820C/zh not_active Expired - Fee Related
- 2002-05-13 WO PCT/US2002/011884 patent/WO2002094833A1/en not_active Ceased
- 2002-05-13 AU AU2002339268A patent/AU2002339268B2/en not_active Ceased
- 2002-05-13 HU HU0400451A patent/HU228844B1/hu not_active IP Right Cessation
- 2002-05-13 BR BR0209939-0A patent/BR0209939A/pt not_active Application Discontinuation
- 2002-05-15 DZ DZ023506A patent/DZ3506A1/fr active
- 2002-05-22 EG EG2002050542A patent/EG25614A/xx active
- 2002-05-24 PE PE2002000435A patent/PE20030117A1/es not_active Application Discontinuation
- 2002-05-24 SV SV2002001054A patent/SV2003001054A/es unknown
- 2002-05-24 TW TW091111082A patent/TWI329644B/zh not_active IP Right Cessation
- 2002-05-24 MY MYPI20021941A patent/MY134586A/en unknown
- 2002-05-27 AR ARP020101974A patent/AR036034A1/es not_active Application Discontinuation
-
2003
- 2003-10-20 IL IL158512A patent/IL158512A/en not_active IP Right Cessation
- 2003-10-31 ZA ZA2003/08546A patent/ZA200308546B/en unknown
- 2003-11-18 CO CO03101666A patent/CO5540282A2/es active IP Right Grant
- 2003-11-21 EC EC2003004859A patent/ECSP034859A/es unknown
- 2003-11-21 NO NO20035193A patent/NO326701B1/no not_active IP Right Cessation
-
2007
- 2007-09-17 CY CY20071101193T patent/CY1106871T1/el unknown
-
2009
- 2009-04-27 JP JP2009108167A patent/JP2009197016A/ja active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0531901A2 (en) * | 1991-09-09 | 1993-03-17 | Fujisawa Pharmaceutical Co., Ltd. | Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity |
| US5597816A (en) * | 1992-06-17 | 1997-01-28 | The Upjohn Company | Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| US5670503A (en) * | 1993-02-26 | 1997-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| EP0666079A1 (en) * | 1993-07-27 | 1995-08-09 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for parkinson's disease |
| US5358947A (en) * | 1993-09-13 | 1994-10-25 | American Cyanamid Company | Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones |
| WO1997035551A1 (fr) * | 1996-03-22 | 1997-10-02 | L'oreal | Compositions de teinture des fibres keratiniques contenant des pyrazolo-azoles; leur utilisation pour la teinture comme coupleurs, procede de teinture |
| EP0923929A1 (fr) * | 1997-12-16 | 1999-06-23 | L'oreal | Compositions de teinture des fibres kératiniques centenant des pyrazolo-azoles; leur utilisation pour la teinture comme base d'oxydation, procédé de teinture; nouveaux pyrazolo-azoles |
| WO2000044743A1 (en) * | 1999-01-28 | 2000-08-03 | Nippon Shinyaku Co., Ltd. | Amide derivatives and drug compositions |
| WO2001016138A1 (en) * | 1999-08-27 | 2001-03-08 | Abbott Laboratories | Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
Non-Patent Citations (5)
| Title |
|---|
| Kuroda S. et al.:"Discovery of FR166124, a novel water-soluble pyrazolo[1,5-a]pyridine adenosine A1 receptor antagonist" Bioorg. Med. Chem. Lett., 1999, vol. 9, no. 1979-1984 (cely dokument) * |
| Pirisino R. et al.:"Further investigations on the inflammatory activity of some 2-phenylpyrazolo[1,5-a]pyrimidine compounds" Farmaco, Ed. Sci., 1981, vol. 36, no. 8, pages 682-691 (str. 683, table 1) * |
| Pirisino R. et al.:"Pharmacological Activity of some pyrazolo[1,5-a]pyrimidines" Farmaco, Ed. Sci., 1979, vol. 34, no. 9, pages 802-807 (str. 803, table 1) * |
| Yamamoto N. et al.:"Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice" Anticancer Res., 1998, vol. 18, no. 1A, pages 139-144 (str. 140, fig. 1) * |
| Yamamoto N. et al.:"Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation" Eur. J. Pharmacol., 1996, vol. 314, pages 137-142 (str. 138) * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ303808B6 (cs) | Nové pyrazolové deriváty jako farmaceutická cinidla | |
| US7365066B2 (en) | Pyrazolopyridine derivatives as pharmaceutical agents | |
| AU2002339268A1 (en) | Novel pyrrole derivatives as pharmaceutical agents | |
| US7405299B2 (en) | Compounds as pharmaceutical agents | |
| US20070208053A1 (en) | Fused heterobicyclic kinase inhibitors | |
| JP2018150358A (ja) | Tank結合キナーゼインヒビター化合物 | |
| KR20230038697A (ko) | Rock 억제제 및 이의 제조 방법과 용도 | |
| NO317367B1 (no) | Ftalaziner med angiogenese-inhiberende aktivitet, anvendelse av forbindelsene samt farmasoytiske preparater inneholdende disse | |
| AU2013343104A1 (en) | Heteroaromatic compounds and their use as dopamine D1 ligands | |
| CN113164459A (zh) | 单酰基甘油脂肪酶调节剂 | |
| JP2024038151A (ja) | モノアシルグリセロールリパーゼ調節因子 | |
| KR20080059184A (ko) | 단백질 키나제 억제제로서의티에노[2,3-b]피리딘-5-카르보니트릴 | |
| HK1064375B (en) | Novel pyrrole derivatives as pharmaceutical agents | |
| HK40014620A (en) | Pyrazole derivatives as malt1 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20180513 |